https://rjrindex.com/articles/ctd402-allogeneic-anti-cd7-car-t-cell-in-relapsed-or-refractory-rr-t-cell-acute-lymphoblastic-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-profile-of-clinical-and-laboratory-features-of-chinese-vexas-syndrome-patients-with-hematologica 2026-08-17 monthly 0.7 https://rjrindex.com/articles/odronextamab-odro-plus-lenalidomide-len-in-patients-with-relapsedrefractory-rr-follicular-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparison-of-real-world-survival-outcomes-and-time-toxicity-of-car-t-cell-versus-bispecific-antibod 2026-08-17 monthly 0.7 https://rjrindex.com/articles/10-day-decitabine-versus-conventional-chemotherapy-37-followed-by-allografting-in-aml-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/updated-results-from-a-phase-ii-study-of-minimal-residual-disease-guided-venetoclax-obinutuzumab-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-nivolumab-based-therapies-in-first-line-and-relapsedrefractory-hodgkin-lymph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrated-multidisciplinary-approaches-to-improve-prognosis-prediction-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dynamic-crosstalk-between-cll-cells-and-lymph-node-fibroblasts-promotes-a-pro-tumor-microenvironment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-line-treatment-in-patients-with-transplant-ineligible-newly-diagnosed-multiple-myeloma-by-age 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-for-anti-cd38-monoclonal-antibody-naive-and-exposed-patients-receiving-treatment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/asxl1-mutations-are-associated-with-adverse-outcomes-in-european-leukemianet-eln-2024-favorable-ri 2026-08-17 monthly 0.7 https://rjrindex.com/articles/initial-treatment-of-chronic-lymphocytic-leukemia-with-low-dose-high-frequency-rituximab-followed-by 2026-08-17 monthly 0.7 https://rjrindex.com/articles/concurrent-loss-of-tp53-and-cdkn2a-with-tetraploidy-predicts-richter-transformation-and-poor-prognos 2026-08-17 monthly 0.7 https://rjrindex.com/articles/primary-prophylaxis-with-direct-oral-anticoagulants-doacs-for-transwomen-taking-estrogen-is-not-co 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-blinatumomab-as-frontline-treatment-for-infant-acute-lymphoblastic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-immune-signature-characterized-by-activation-of-the-ifngh-il18-axis-identifies-immune-effecto 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aggressive-lymphomas-that-are-treated-early-have-worse-outcomes-counterintuitive-results-from-a-nat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/infections-in-patients-with-relapsed-refractory-multiple-myeloma-receiving-idecabtagene-vicleucel-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cerebral-hemodynamic-changes-during-vaso-occlusive-episodes-in-pediatric-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-of-the-t-cell-receptor-like-antibody-hu8f4-in-pts-with-advanced-myeloid-neoplasms 2026-08-17 monthly 0.7 https://rjrindex.com/articles/viral-mimicry-in-aml-is-linked-to-immune-activation-but-not-bcl2-inhibitor-sensitivity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/functional-investigation-into-nk-cells-identifies-salt-inducible-kinases-as-novel-therapeutic-target 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-factors-and-outcomes-of-carbapenem-resistant-and-multidrug-resistant-klebsiella-pneumoniae-bloo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sipa1-loss-in-host-niche-boosts-anti-aml-immune-response 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-acute-myeloid-leukemia-mortality-among-patients-with-diabetes-mellitus-in-the-united-state 2026-08-17 monthly 0.7 https://rjrindex.com/articles/investigating-ribosome-biogenesis-in-aml-identifies-myb-binding-protein-1a-mybbp1a-as-an-essential 2026-08-17 monthly 0.7 https://rjrindex.com/articles/poseltinib-combined-with-rituximab-and-lenalidomide-is-a-promising-chemotherapy-free-therapy-in-rela 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-prognosis-of-venetoclax-combined-with-the-37-regimen-in-fit-aml-a-propensity-score-ma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reduced-intensive-chemotherapy-combined-with-venetoclax-in-adult-patients-with-acute-myeloid-leukemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/its-that-time-of-the-month-menstrual-suppression-among-adolescents-and-young-adults-with-cancer-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ai-multimodal-large-language-model-on-car-t-pre-leukapheresis-evaluation-to-predict-monitoring-needs 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nationwide-impact-of-car-t-approval-on-acute-lymphoblastic-leukemia-mortality-in-the-united-states 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-progression-free-and-overall-survival-between-idecabtagene-vicleucel-ide-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/diagnostic-relevance-of-sh2b3-mutations-in-suspected-myeloid-malignancies-insights-from-a-large-sca 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mortality-trends-and-disparities-in-purpura-and-related-hemorrhagic-conditions-in-the-elderly-popula 2026-08-17 monthly 0.7 https://rjrindex.com/articles/post-transplant-cyclophosphamide-facilitates-preservation-of-intestinal-innate-lymphoid-cells-and-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-partial-neutralizing-antibody-to-protein-c-hemophilic-bleeding-preventive-effects-and-thrombotic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-related-outcomes-of-very-old-ampgt85-years-diffuse-large-b-cell-lymphoma-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/understanding-secondary-immunodeficiency-management-in-patients-with-hematological-malignancies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/potential-paradoxical-hemostatic-function-of-adamts13-by-enhancing-collagen-induced-platelet-aggrega 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-cd20xcd3-bispecific-antibody-therapy-as-holding-or-bridging-therapy-prior-to-chimeric-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pentostatintbi-conditioning-for-allogeneic-transplantation-in-t-cell-lymphomas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/challenge-to-redifferentiate-b-lymphocyte-derived-ips-cells-carrying-t1114-with-or-without-p53-ba 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-immunophenotyping-in-acquired-hemophilia-a-reveals-an-imbalanced-immune-activation-lands 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-and-impact-of-acute-coronary-syndrome-on-outcomes-in-chimeric-antigen-receptor-t-cell-ther 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-initiation-monitoring-and-interventions-after-acalabrutinib-lead-in-for-chronic-lymphocyt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/applying-computational-modelling-to-a-high-risk-multiple-myeloma-data-set-to-create-novel-risk-strat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/measurable-residual-disease-mrd-assessment-as-an-early-end-point-oftreatment-efficacy-in-acute-mye 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-implications-of-commutational-patterns-in-npm1-mutated-aml-receiving-intensive-treatment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ruxolitinib-and-interferon-alfa-induce-superior-rates-of-complete-peripheral-blood-count-remission-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-predictors-of-anemia-response-to-momelotinib-in-patients-with-myelofibrosis-real-world-ou 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interim-analysis-of-promise-a-clinical-study-combining-the-bet-inhibitor-opn-2853-with-ruxolitinib 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-transition-from-chip-to-overt-myeloproliferative-neoplasms-a-13-year-longitudinal-study-of-jak2 2026-08-17 monthly 0.7 https://rjrindex.com/articles/randomized-comparison-between-isatuximab-rd-versus-rd-induction-followed-by-isa-r-versus-r-maintena 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-cytogenetic-and-molecular-characteriszation-of-mecom-rearranged-pediatric-de-novo-acute-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-and-molecular-underpinnings-of-donor-cell-derived-neoplasm-among-spanish-transplantation-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/relapse-with-post-transplant-tyrosine-kinase-inhibitor-tki-maintenance-therapy-in-phliladelphia-ch 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-multicenter-real-world-analysis-of-combined-chemotherapy-followed-by-consolidative-radiation-versu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-clia-plus-venetoclax-as-salvage-therapy-for-relapsed-or-refractory-acute-myel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-of-cd34-cell-dose-on-outcome-after-reduced-intensity-conditioning-allogeneic-peripheral 2026-08-17 monthly 0.7 https://rjrindex.com/articles/accelerating-practical-solutions-for-bispecific-antibody-consideration-for-multiple-myeloma-in-the-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-cpx-351-in-high-risk-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-older-or-unfit-aml-patients-admitted-to-intensive-care-unit-in-the-venetoclax-era 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-car-t-therapy-in-hiv-positive-multiple-myeloma-patients-a-retrospective-database-analys 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nras-mutation-drives-excessive-netosis-and-differentiation-syndrome-in-acute-promyelocytic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-heparin-induced-thrombocytopenia-hit-diagnostic-strategies-rapid-pf4hepari 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prenatal-transplantation-of-a-clinical-cell-product-engineered-to-secrete-fviii-in-a-sheep-with-hemo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survival-difference-among-patients-with-large-b-cell-lymphoma-lbcl-based-on-first-line-clinical-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-report-of-successful-lifesaving-and-timely-graft-rescue-using-an-off-the-shelf-cryopreserved 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-1-dose-escalation-and-dose-optimization-study-to-evaluate-the-preliminary-safety-tolerabili 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aged-b-cells-as-a-candidate-cell-of-origin-for-diffuse-large-b-cell-lymphoma-a-multi-modal-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-novel-surfaceome-classification-system-for-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-characterization-of-pediatric-acute-myeloid-leukemia-treated-under-the-nopho-dbh-2012-prot 2026-08-17 monthly 0.7 https://rjrindex.com/articles/atypical-neurotoxicity-in-car-t-cell-therapy-a-retrospective-analysis-of-unusual-icans-presentation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-following-second-hematopoietic-cell-transplantation-in-lymphoma-and-leukemia-a-si 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tfr2-mediated-erythropoiesis-expansion-controls-systemic-glucose-homeostasis-by-modulating-erythroid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-in-patients-with-multiple-myeloma-and-antidepressant-use-a-retrospective-cohort-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-severe-infection-risk-and-survival-outcomes-in-dlbcl-patients-treated-with-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-innate-immune-memory-on-mds-progression-by-tet2-driven-inflammation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deficiency-of-mrpl57-in-acute-myeloid-leukemia-patients-leads-to-suboptimal-therapeutic-outcomes-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-predictors-of-mortality-in-patients-with-essential-thrombocytosis-and-concurre 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epidemiological-characteristics-of-myeloproliferative-neoplasms-in-brazil-a-multicenter-retrospecti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/selinexor-based-regimens-in-triple-class-exposed-or-refractory-multiple-myeloma-a-real-world-analys 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tp53-exon-7-c742campgtt-p-arg248trp-vaf-suppression-by-novel-oral-allosteric-nek7-inhibitor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/kit-mutantcore-binding-factor-cbf-negative-cbf-neg-aml-might-be-an-underestimated-and-distinct 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mortality-trends-in-patients-with-mantle-cell-lymphoma-with-or-without-a-covid-19-diagnosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disruption-of-the-gut-microbiota-promotes-chronic-inflammation-in-jak2v617f-driven-mpn-evidence-fro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effect-of-race-and-socio-economic-status-in-allogeneic-stem-cell-transplantation-a-single-center-ex 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phenotyping-of-ex-vivo-expanded-nk-cells-reveals-unique-transcriptomic-and-epigenetic-signatures 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-cxcr4-mutation-type-on-clinical-features-and-outcomes-of-patients-with-waldenst 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disruption-of-neat1-transcriptional-network-identifies-targetable-non-genetic-dependencies-in-multip 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-human-il-6-expressing-pdx-model-of-multiple-myeloma-recapitulates-clinical-features-and-supports-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/modeling-del17p-in-multiple-myeloma-for-molecular-and-functional-characterization 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeted-immunotherapy-in-children-adolescents-and-young-adults-caya-with-newly-diagnosed-classi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-mortality-from-hematological-cancers-with-atrial-fibrillation-and-flutter-as-cont 2026-08-17 monthly 0.7 https://rjrindex.com/articles/elevated-d-dimer-predicts-worse-outcomes-in-hospitalized-adults-with-sickle-cell-crisis-a-real-worl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cancer-specific-risk-and-mortality-due-to-autoimmune-hemolytic-anemia-aiha-associated-with-immune 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-accuracy-transfusion-aware-machine-learning-pipeline-for-hemoglobin-genotype-classification-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/digital-pcr-based-dynamic-monitoring-of-jak2v617f-burden-a-decade-long-study-unravels-its-prognosti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-and-treatment-influences-on-diffuse-large-b-cell-lymphoma-survival-a-10-year-safe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allograft-for-myeloid-malignancies-in-the-year-of-70-years-old-and-beyond-no-impact-of-pre-graft-im 2026-08-17 monthly 0.7 https://rjrindex.com/articles/therapeutic-outcomes-of-glofitamab-based-regimens-in-chinese-patients-with-relapsedrefractory-b-cel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epigenetic-dysregulation-of-the-polycomb-axis-in-acute-myeloid-leukemia-clinical-and-prognostic-cor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ivig-successfully-halts-a-recurrent-hyperhaemolysis-syndrome-in-a-young-patient-with-sickle-cell-cri 2026-08-17 monthly 0.7 https://rjrindex.com/articles/extracellular-vesicle-dynamics-as-biomarkers-in-sickle-cell-disease-across-therapies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/germline-osmr-mutation-drives-familial-unicentric-castleman-disease-with-osteosclerosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patient-and-clinician-perspectives-on-the-diagnosis-and-management-of-polycythemia-vera-results-fro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chromomycin-a2-exhibits-antileukemic-effects-by-coordinated-disruption-of-survival-pathways 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-the-use-of-anabolic-bone-agents-in-patients-with-underlying-plasma-cell-dyscr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sequential-cd19-and-cd22-cart-for-relapsed-and-refractory-b-cell-all-phase-i-results 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinguishing-on-target-efficacy-and-off-target-toxicity-with-antibody-drug-conjugates-adcs-on-di 2026-08-17 monthly 0.7 https://rjrindex.com/articles/role-of-race-in-severity-and-survival-of-those-with-cutaneous-t-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-ras-mutations-on-outcomes-in-newly-diagnosed-aml-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-and-comorbidity-of-multiple-myeloma-among-us-adults-with-stroke-a-cdc-wonder 2026-08-17 monthly 0.7 https://rjrindex.com/articles/glofitamab-use-may-significantly-reduce-the-efficacy-of-car-t-therapy-in-rr-dlbcl-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/renal-and-urinary-adverse-events-following-car-t-therapy-a-faers-based-pharmacovigilance-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/engineered-platelets-as-immune-modulators-a-novel-strategy-to-prevent-fviii-inhibitor-formation-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pnh-driven-hepatic-vein-thrombosis-a-case-of-budd-chiari-syndrome-in-disguise 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aberrant-thymic-architecture-and-enhanced-interferon-signaling-in-down-syndrome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nanobody-based-cd19cd20-bispecific-car-t-achieves-durable-remissions-in-rr-nhl-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-hospital-stroke-myocardial-infarction-and-venous-thrombosis-in-immune-thrombocytopenia-inciden 2026-08-17 monthly 0.7 https://rjrindex.com/articles/protac-mediated-degradation-of-neutrophil-elastase-as-a-potential-therapeutic-strategy-for-elane-rel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prospective-hydroxyurea-impact-on-cerebral-magnetic-resonance-imaging-from-a-30-month-trial-of-child 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-pts-with-higher-risk-myelodysplastic-syndromes-hr-mds-treated-with-hypometh 2026-08-17 monthly 0.7 https://rjrindex.com/articles/indirect-treatment-comparison-of-novel-jak2-inhibitor-ob756-versus-ruxolitinib-in-polycythaemia-vera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/therapy-related-core-binding-factor-acute-myeloid-leukemia-cbf-aml-responds-favorably-to-fludarabi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/avatrombopag-improves-platelet-engraftment-after-haploidentical-hematopoietic-stem-cell-transplantat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-neutrophil-to-lymphocyte-ratio-does-not-predict-mgus-to-myeloma-progression-but-is-associated-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-a-novel-initial-regimen-rituximab-plus-pegylated-interferon-a-2b-in-untreated 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-rw-use-of-fixed-duration-fd-ibrutinibvenetoclax-ibrven-in-patients-pts-with-pre 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterization-of-ighv-subgroups-and-their-prognostic-relevance-in-cll 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improve-therapeutic-response-through-inhibition-of-endosome-machinery-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-in-high-risk-patients-with-chronic-lymphocytic-leukemia-treated-with-targeted-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-12-multi-center-open-label-clinical-study-to-evaluate-the-safety-pharmacokinetics-and-eff 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-2-trial-of-romiplostim-n01-versus-recombinant-human-thrombopoietin-for-promoting 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-reversal-strategies-for-long-acting-factor-xi-antibodies-rfviia-feiba-kcentra-nove 2026-08-17 monthly 0.7 https://rjrindex.com/articles/adamts13-variant-r1206k-exhibits-increased-vwf-cleaving-activity-and-inhibition-of-thrombus-format 2026-08-17 monthly 0.7 https://rjrindex.com/articles/blocking-fcghriii-with-anti-cd16-mab-3g8-and-gma161-increases-platelets-in-immune-thrombocytopenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-synthetic-data-generation-over-a-federated-learning-computing-framewor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/response-to-hetrombopag-among-patients-with-acute-and-persistent-primary-immune-thrombocytopenia-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-ibii-trial-of-epcoritamab-plus-ibrutinib-in-patients-with-relapsedrefractory-aggressive-b-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/secondary-analysis-results-from-vayhit3-a-phase-2-study-of-ianalumab-in-patients-with-primary-immun 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disaggregating-aggressive-atll-a-retrospective-study-focused-on-the-lymphomatous-variant-in-latin-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lentiviral-hematopoietic-stem-and-progenitor-cell-gene-therapy-for-wiskott-aldrich-syndrome-early-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lbl-076-a-first-in-class-gprc5dxcd38xcd3-trispecific-t-cell-engager-tce-for-the-treatment-of-rela 2026-08-17 monthly 0.7 https://rjrindex.com/articles/luspatercept-response-predictors-in-lower-risk-myelodysplastic-syndrome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-myeloid-transcriptional-signature-stratifies-outcomes-in-newly-diagnosed-etp-all 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterising-the-leukaemic-microenvironment-in-a-mouse-model-of-infant-aml-with-prenatal-kmt2a-mll 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cytogenetic-testing-in-newly-diagnosed-multiple-myeloma-ndmm-real-world-evidence-of-adverse-outco 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pre-emptive-multidisciplinary-approach-to-overcome-the-negative-impact-of-high-psychosocial-risk-fac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-identification-of-patients-likely-to-benefit-from-paroxysmal-nocturnal-hemoglobinuria-workup-u 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-of-second-primary-hematological-malignancy-post-chimeric-antigen-receptor-t-cell-therapy-in-dif 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effect-of-white-blood-count-and-absolute-monocyte-count-on-kidney-function-in-chronic-myelomonocytes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/low-incidence-of-agvhd-with-ptcy-tacrolimus-and-post-engraftment-low-dose-atg-based-gvhd-prophylaxi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hematopoietic-stem-cell-transplantation-with-reduced-toxicity-myeloablative-conditioning-regimen-for 2026-08-17 monthly 0.7 https://rjrindex.com/articles/idh-mutant-mds-proposal-for-disease-subset-recognition-based-on-molecular-and-clinical-features-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-short-course-blinatumomab-immunotherapy-as-a-bridge-to-hsct-in-ph-negative-b-cell-ac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-role-of-hypomethylating-agents-and-venetoclax-combination-in-higher-risk-myelodysplastic-syndrom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinctive-features-of-patients-with-mpn-during-pregnancy-thrombotic-risk-molecular-drivers-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/parental-perspectives-on-financial-distress-during-treatment-for-childhood-acute-lymphoblastic-leuke 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhancing-the-expansion-of-naive-potent-t-cells-via-btk-inhibition-reinvigorates-cd19-car-t-cell-im 2026-08-17 monthly 0.7 https://rjrindex.com/articles/orelabrutinib-for-elderly-patients-with-stage-iv-marginal-zone-lymphoma-involving-the-central-nervou 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sf3b1-mutations-k700e-k666n-and-r625h-gene-expression-and-aberrant-splicing-consequences 2026-08-17 monthly 0.7 https://rjrindex.com/articles/peripheral-blood-and-bone-marrow-immune-profiles-are-strongly-correlated-in-patients-with-plasma-cel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nsun2ybx1-mediated-m5c-modification-enhances-phgdh-expression-to-drive-immune-evasion-via-pd-l1-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/crlf2-rearrangement-and-extramedullary-disease-in-b-cell-acute-lymphoblastic-leukemia-a-possible-li 2026-08-17 monthly 0.7 https://rjrindex.com/articles/serineglycine-starvation-induces-metabolic-rewiring-to-uncover-atf4-driven-therapeutic-vulnerabilit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effect-of-baseline-hemoglobin-on-survival-in-renal-cell-cancer-patients-on-tyrosine-kinase-inhibitor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patient-engagement-and-perceived-impact-of-clinical-trials-in-hematology 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multicenter-real-world-outcomes-in-limited-stage-ls-diffuse-large-b-cell-lymphoma-dlbcl-treated 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-cyclosporine-and-antithymocyte-or-antilymphocyte-globulin-in-the-management-of-aplastic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-for-allogeneic-transplant-in-myelofibrosis-remain-suboptimal-in-the-modern-era-despite-incr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/replication-fork-remodeling-is-a-therapeutic-vulnerability-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-multinational-study-to-explore-patient-preferences-for-chronic-myeloid-leukaemia-treatments 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-a-doctor-in-the-loop-ai-agent-for-multiple-myeloma-chart-reviews 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterisation-of-the-wnt-signalling-responsive-surfaceome-of-myeloid-cells-reveals-plp2-as-a-regu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allele-dependent-activity-of-promoters-of-genes-slc22a4-and-slc22a5-encoding-imatinib-transporters-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preclinical-characterization-of-a-novel-wild-type-sparing-jak2-v617f-mutant-selective-inhibitor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-of-postpartum-hemorrhage-in-women-with-von-willebrand-disease-by-treatment-type-an-analysis-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/humanistic-and-economic-burden-among-caregivers-of-adults-and-children-with-sickle-cell-disease-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multiple-myeloma-genetic-alterations-have-distinct-repertoires-and-prognostic-implications-in-africa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identification-of-stage-specific-regulators-for-neutrophil-granule-biogenesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/iron-infusions-in-pregnant-women-are-associated-with-comparable-efficacy-and-safety-compared-to-non 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genetic-deletion-of-vasoactive-intestinal-peptide-vip-and-pi3k-signaling-pathways-impair-car-t-cel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-pretreatment-neutrophil-to-lymphocyte-ratio-for-overall-survival-in-prim 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-line-therapy-with-rituximab-vs-rituximab-chop-in-post-transplant-monomorphic-diffuse-large-b 2026-08-17 monthly 0.7 https://rjrindex.com/articles/oral-azacitidine-as-maintenance-therapy-post-allogeneic-stem-cell-transplant-in-patients-with-myeloi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/switching-between-complement-inhibitors-in-patients-with-pnh-a-real-world-analysis-of-strategy-eff 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dogs-with-acute-leukemia-have-shared-and-unique-genetic-mutations-compared-to-human-acute-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-analysis-of-central-nervous-system-leukemia-in-patients-with-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/low-protein-expression-of-janus-kinase-2-jak2-is-prognostically-adverse-and-independent-of-mutatio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-treatment-strategies-and-response-patterns-in-evans-syndrome-initial-ana 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-hla-evolutionary-divergence-mismatch-increases-the-risk-of-acute-graft-versus-host-disease-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-lisocabtagene-maraleucel-monotherapy-in-relapsed-or-refractory-large-b-cell-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/weight-based-dosing-of-alemtuzumab-as-part-of-an-enhanced-lymphodepletion-regimen-may-mitigate-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-population-dynamics-predict-multiple-myeloma-progression-while-on-daratumumab-maintenance-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hmga1-chromatin-regulators-drive-transcriptional-networks-involved-in-megakaryocyte-expansion-fibro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epitranscriptomic-signatures-define-prognosis-and-therapeutic-vulnerabilities-in-large-b-cell-lympho 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disparities-in-venous-thromboembolism-management-in-patients-with-sickle-cell-disease-a-nationwide 2026-08-17 monthly 0.7 https://rjrindex.com/articles/splenomegaly-patterns-and-clinical-impact-in-african-children-with-sickle-cell-anemia-on-hydroxyurea 2026-08-17 monthly 0.7 https://rjrindex.com/articles/antiviral-efficacy-of-ebv-and-cmv-bispecific-cytotoxic-t-lymphocytes-following-allogeneic-hematopoie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/neo-201-based-car-nk-cells-as-a-novel-immunotherapeutic-approach-to-target-truncated-core-1-o-glycan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-a-virtual-reality-headset-for-managing-severe-pain-during-sickle-cell-vaso-occlusive-cri 2026-08-17 monthly 0.7 https://rjrindex.com/articles/assessing-quality-metrics-in-sickle-cell-disease-a-multicenter-review-of-community-hospitals-in-sou 2026-08-17 monthly 0.7 https://rjrindex.com/articles/elevated-aptt-in-the-setting-of-prophylactic-unfractionated-subcutaneous-heparin-administration 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-thiotepa-containing-conditioning-regimen-for-haploidentical-hematopoietic-cell-transplantati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/earlier-detection-of-transplant-associated-thrombotic-microangiopathy-using-harmonization-criteria 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-long-term-luspatercept-treatment-on-iron-parameters-in-patients-with-transfusion-dependent 2026-08-17 monthly 0.7 https://rjrindex.com/articles/travel-time-and-insurance-status-as-determinants-of-specialized-leukemia-care-access-in-adolescents 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inflammation-triggered-thrombotic-thrombocytopenic-purpura-a-case-series-highlighting-diagnostic-pi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/social-determinants-and-hospital-outcomes-in-waldenstroms-macroglobulinemia-a-nationwide-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-outcomes-associated-with-atrial-fibrillation-in-patients-hospitalised-with-non-hodgkin-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/external-validation-of-the-early-stage-classic-hodgkin-lymphoma-chl-international-prognostication 2026-08-17 monthly 0.7 https://rjrindex.com/articles/embryonic-ectoderm-development-eed-inhibitor-apg-5918-overcomes-immunomodulatory-drug-imid-resis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/parkinsonism-after-treatment-with-anti-cd19-car-t-case-report-institutional-data-review-and-pharm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-predictors-of-survival-in-patients-with-myeloproliferative-neoplasm-blast-phase-mpn-bp-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-l-dose-escalation-and-expansion-of-ziftomenib-in-combination-with-quizartinib-in-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/primary-analysis-of-the-phase-3-randomized-trial-of-selinexor-and-lenalidomide-versus-lenalidomide-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prevalence-of-iron-deficiency-with-or-without-anemia-in-adults-a-systematic-review-and-meta-analysi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fixed-duration-epcoritamab-in-combination-with-bendamustine-rituximab-br-for-first-line-1l-tre 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trilaciclib-for-the-prevention-of-chemotherapy-induced-myelosuppression-a-systematic-review-and-met 2026-08-17 monthly 0.7 https://rjrindex.com/articles/glofitamab-for-patients-with-non-large-b-cell-lymphoma-refractory-or-relapsing-after-anti-cd19-car-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-mds-associated-mutations-and-age-on-outcomes-in-npm1-mutated-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patients-with-tp53-mutated-amlmds-without-complex-or-monosomal-karyotype-can-achieve-durable-surviv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/validation-of-baseline-total-metabolic-tumor-volume-tmtv-as-a-predictor-of-early-progression-pod2 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-hdac-iiib-selective-inhibitor-purinostat-mesylate-in-relapsed-and-refractory-peripheral-t-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dapagliflozin-for-treatment-of-sickle-cell-nephropathy-a-multi-centre-experience 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-frontline-polatuzumab-rchp-and-impact-of-frailty-in-older-adults-with-diffuse 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeted-long-read-sequencing-with-adaptive-sampling-in-multiple-myeloma-a-pilot-study-toward-a-uni 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gut-microbiota-and-metabolomic-profiling-in-relapsedrefractory-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-sequencing-of-bone-marrow-cells-and-peripheral-mononuclear-cells-reveals-immune-features 2026-08-17 monthly 0.7 https://rjrindex.com/articles/supportive-care-alone-is-effective-for-managing-low-grade-crs-in-multiple-myeloma-patients-treated-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-pivekimab-sunirine-in-combination-with-venetoclax-plus-azacitidine-in-unfit-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/missense-mutations-in-the-pwwp-domain-of-dnmt3a-can-cause-cytoplasmic-mislocalization-of-dnmt3a-in-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lipid-nanoparticle-mediated-epitope-editing-in-human-hspcs-enables-resistance-to-cd45-directed-car-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-in-children-and-adolescents-with-down-syndrome-and-b-lymphoblastic-leukemia-a-report-from 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cytoreductive-therapy-reduces-recurrent-thrombosis-in-patients-with-myeloproliferative-neoplasm-asso 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-sialylation-profiles-of-neonatal-and-adult-platelets-revealed-by-lectin-flow-cytometry 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-in-vivo-car-platform-for-autoimmune-disease-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/systematic-literature-review-and-meta-analysis-on-the-safety-of-fibrinogen-concentrate-versus-cryopr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-the-triplet-therapy-with-venetoclax-azacitidine-and-gilteritinib-for-the-treatment-of-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prevalence-and-outcomes-of-inherited-and-acquired-thrombophilia-in-pediatric-patients-with-venous-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/engineered-biomimetic-platelet-membrane-coated-nanoparticles-as-platelet-decoys-to-reduce-coagulopat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-study-on-the-efficacy-safety-and-mechanism-of-venetoclax-combined-with-car-t-targeting-cll1-in-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pet-adaptive-beacopp-versus-abvd-based-therapies-for-advanced-stage-as-classic-hodgkin-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/relapsedrefractory-hodgkin-lymphoma-after-first-line-escalated-beacopdac-adverse-outcomes-are-over 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-landscape-characterization-of-relapsedrefractory-b-cell-lymphoma-patients-treated-with-cd19 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-profile-of-inaticabtagene-autoleucel-in-chinese-patients-with-philadelphia-chrom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immunotherapy-without-or-with-low-intensity-chemotherapy-versus-standard-chemotherapy-as-first-line 2026-08-17 monthly 0.7 https://rjrindex.com/articles/budget-impact-analysis-for-sickle-cell-disease-point-of-care-testing-in-mozambique 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evolutionary-divergence-of-polymorphic-hla-residues-predicts-clinical-outcomes-after-haploidentical 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reduced-post-transplant-alpha-diversity-and-domination-by-enterococcus-faecium-are-associated-with-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-radiofrequency-therapy-in-management-of-sickle-cell-disease-chronic-pain 2026-08-17 monthly 0.7 https://rjrindex.com/articles/echocardiographic-findings-over-time-in-sickle-cell-disease-patients-a-single-center-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-role-of-palliative-care-in-sickle-cell-disease-a-single-database-literature-review-of-contempor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-sequencing-reveals-the-impact-of-low-dose-vs-standard-dose-chemotherapy-and-infection-on 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-and-lung-adenocarcinoma-pathogenesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/uba1a-dependency-leads-to-synthetic-lethality-in-vacuoles-e1-ligase-x-linked-auto-inflammatory-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-nog-w41-based-humanized-mouse-model-for-studying-in-vivo-human-hematopoiesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-short-form-case-based-continuing-medical-education-on-clinician-knowledge-and-competence 2026-08-17 monthly 0.7 https://rjrindex.com/articles/differences-in-peripheral-neuropathy-reports-by-race-informed-by-electronic-patient-reported-outcome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-clinical-outcomes-of-offspring-versus-matched-sibling-donor-hematopoietic-stem-cell-tran 2026-08-17 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-lymphoma-meta-analytic-insights-into-diagnosis-and-survival-gaps 2026-08-17 monthly 0.7 https://rjrindex.com/articles/polatuzumab-vedotin-in-large-diffuse-b-cell-lymphoma-a-multicenter-observational-study-from-latin-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/we-know-what-we-need-exploring-the-communicative-and-structural-gaps-in-support-for-caregivers-of-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-line-venetoclax-based-regimens-versus-chemoimmunotherapy-in-chronic-lymphocytic-leukemia-a-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/from-deficiency-to-competency-strategies-to-strengthen-classical-hematology-training-across-the-uni 2026-08-17 monthly 0.7 https://rjrindex.com/articles/car-t-cells-co-targeting-bcma-and-cd19-in-rrmm-results-from-the-ukmra-phase-1-mcarty-trial-in-relap 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitors-impact-on-outcomes-of-relapsed-and-refractory-hodgkin-lymphoma-a-real 2026-08-17 monthly 0.7 https://rjrindex.com/articles/simultaneous-pd-1-and-vip-receptor-blockade-optimizes-tumor-immunotherapy-in-p815-acute-myeloid-leuk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/longitudinal-analysis-of-first-and-subsequent-line-tyrosine-kinase-inhibitor-use-in-chronic-myeloid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/adding-selinexor-to-ifosfamide-etoposide-and-desametasone-does-not-improve-the-outcome-in-relapsed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/retrospective-analysis-of-mortality-and-morbidity-among-thrombotic-thrombocytopenia-purpura-presenti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-cav-cladribine-cytarabine-and-venetoclax-regimen-in-patients-with-newly-di 2026-08-17 monthly 0.7 https://rjrindex.com/articles/from-juvenile-idiopathic-arthritis-to-blastic-plasmacytoid-dendritic-cell-neoplasm-a-diagnostic-ody 2026-08-17 monthly 0.7 https://rjrindex.com/articles/snai2-orchestrates-a-hypo-oxidative-mitochondrial-phenotype-with-elevated-fao-dependence-in-acute-my 2026-08-17 monthly 0.7 https://rjrindex.com/articles/esam-is-functionally-involved-in-the-activity-of-cancer-stem-like-cells-in-human-acute-myeloid-leuke 2026-08-17 monthly 0.7 https://rjrindex.com/articles/do-patients-with-classic-hodgkins-lymphoma-treated-with-abvd-in-low-middle-income-countries-have-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-prognosis-and-transplant-timing-in-core-binding-factor-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-versus-double-73-induction-with-60-versus-90-mgm2-daunorubicin-in-newly-diagnosed-aml-do 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nup98-rearrangements-nup98r-in-acute-myeloid-leukemia-aml-a-genomic-landscape-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epik-l1-a-phase-23-study-of-alpelisib-in-pediatric-and-adult-patients-with-pik3ca-driven-lymphatic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pre-chemotherapy-microbiome-dysbiosis-in-hematologic-malignancies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-safety-of-polatuzumab-vedotin-in-real-world-clinical-practice-in-chinese-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-real-world-outcomes-among-cll-patients-based-on-sequencing-of-btki-and-bcl2i-therapies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/zanubrutinib-is-well-tolerated-and-effective-in-acalabrutinib-intolerant-patients-with-b-cell-malign 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comprehensive-analysis-of-long-term-outcomes-in-adult-patients-with-acute-lymphoblastic-leukemia-who 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-and-risk-factors-of-epstein-barr-virus-reactivation-and-post-transplant-lymphoproliferativ 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thrombotic-microangiopathy-among-hospitalized-patients-demographic-characteristics-diagnostic-tren 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-small-molecule-inhibitors-of-mitochondrial-permeability-transition-pore-mptp-block-platelet 2026-08-17 monthly 0.7 https://rjrindex.com/articles/achieving-jak2v617f-vaf-amplt20-is-associated-with-prolonged-event-free-survival-in-polycythemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chronic-graft-versus-host-disease-after-haploidentical-transplantation-in-aplastic-anemia-clinical 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inhibition-of-drp1-fis1-mediated-mitochondrial-fission-as-a-novel-strategy-to-prevent-gvhd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/promising-safety-and-efficacy-of-equecabtagene-autoleucel-eque-cel-followed-asct-in-ultra-high-ris 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improving-outcomes-with-nivolumab-consolidation-among-older-patients-65-with-previously-untreated 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-treatment-compliance-and-tolerability-with-fitusiran-antithrombin-based-dose-regimen-in-people 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characteristics-survival-and-causes-of-death-in-patients-with-apl-from-chile 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-pre-existing-cardiovascular-disease-on-inpatient-arrhythmias-following-autologous-stem-cel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-in-older-adults-60-years-with-normal-karyotype-acute-myeloid-leukemia-treated-with-inten 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-1-clinical-trial-of-point-of-care-manufactured-fully-human-anti-cd19-car-t-cells-for-treatmen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/complete-blood-count-monitoring-for-patients-on-anticoagulation-with-direct-oral-anticoagulants-for 2026-08-17 monthly 0.7 https://rjrindex.com/articles/modulation-of-the-lipid-metabolism-in-macrophages-through-chaperone-mediated-autophagy-in-primary-im 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ofirnoflast-suppresses-heme-induced-inflammation-representing-a-novel-therapeutic-strategy-for-hemo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-clinical-outcomes-from-the-smart-start-trial-rituximab-lenalidomide-and-ibrutinib-in-pat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identification-of-xpo1-interactors-and-modulation-by-selinexor-in-diffuse-large-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/predictors-of-clinically-relevant-bleeding-during-extended-anticoagulation-for-cancer-associated-ven 2026-08-17 monthly 0.7 https://rjrindex.com/articles/increased-teclistamab-dosing-interval-improves-t-cell-diversity-and-reduces-infection-risk-while-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/intermediatedose-cytarabine-is-noninferior-to-highdose-cytarabine-for-aml-consolidation-a-systema 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-response-in-olutasidenib-treated-relapsedrefractory-midh1-acute-myeloi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-plus-azacitidine-vs-traditional-chemotherapy-in-younger-patients-with-acute-myeloid-leuk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/less-plasma-less-drama-a-quality-improvement-initiative-to-reduce-inappropriate-plasmatransfusions 2026-08-17 monthly 0.7 https://rjrindex.com/articles/from-society-committees-to-clinical-care-navigating-the-divide-between-platelet-transfusion-thresho 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chemotherapy-related-toxicities-and-healthcare-burden-in-acute-myeloid-leukemia-a-nationwide-inpati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-tale-of-two-lymphomas-a-rare-case-of-transformative-post-transplant-lymphoproliferative-disorder 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-intensity-in-older-adults-with-aml-impact-of-age-and-induction-regimen-on-remission-and-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chemo-free-regimen-based-on-venetoclax-and-azacytidine-as-induction-therapy-for-adults-with-newly-di 2026-08-17 monthly 0.7 https://rjrindex.com/articles/examining-diet-quality-and-patient-reported-outcomes-in-myeloproliferative-neoplasms-results-from-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/functional-characterization-of-a-novel-germline-jak2-r989fs-mutation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/endemic-infections-following-car19-t-cell-therapy-real-life-evidence-in-single-center-in-brazil 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-insights-from-the-largest-cohort-to-date-elucidating-risk-factors-clinical-outcomes-and-pro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evolving-annual-community-health-worker-time-allocation-to-maximize-sickle-cell-disease-medical-home 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patterns-risk-factors-and-management-of-cd19-directed-chimeric-antigen-receptor-t-cell-therapy-fail 2026-08-17 monthly 0.7 https://rjrindex.com/articles/adapting-the-american-society-of-hematology-crti-la-model-to-build-clinical-research-capacity-in-mex 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd19cd22-car-t-cells-in-adult-patients-with-relapsedrefractory-b-cell-malignancies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-total-blood-n-glycome-landscape-of-hematological-malignancies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-social-determinants-of-health-on-access-to-molecular-targeted-therapy-in-aml-and-mds-a-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-report-of-ai-derived-metrics-from-whole-body-mri-in-patients-with-multiple-myeloma-reveals-uni 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-mutations-may-influence-cytokine-expression-and-critical-illness-subphenotyping-in-septic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/isotype-specific-heavylight-chain-quantification-identifies-prognostic-biomarkers-after-ari0002h-bc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterizing-a-racially-diverse-cohort-of-patients-with-al-amyloidosis-treated-with-dara-vcd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-of-pediatric-patients-pts-with-relapsedrefractory-b-cell-acute-lymphoblastic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pooled-analysis-of-early-phase-trials-highlights-robust-activity-of-cd3-cd20-t-cell-engagers-in-foll 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fatigue-hemoglobin-and-inflammatory-markers-in-warm-autoimmune-hemolytic-anemia-analysis-from-a-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/this-is-hitting-the-heparin-sweet-spot-here-is-a-retrospective-analysis-of-investigating-and-optimi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mutational-patterns-and-prognosis-in-younger-versus-older-aml-patients-with-myelodysplasia-related-g 2026-08-17 monthly 0.7 https://rjrindex.com/articles/baseline-pet-ct-in-predicting-crs-and-survival-outcomes-of-rr-mm-patients-following-car-t-cell-ther 2026-08-17 monthly 0.7 https://rjrindex.com/articles/predictors-of-outcomes-to-allogeneic-hematopoietic-cell-transplantation-allo-hct-for-tp53-mutant-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/discovery-of-jnj-87562761-a-novel-anti-gprc5d-enhanced-effector-function-eef-antibody-with-multip 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-bcaa-metabolism-induces-synthetic-lethality-in-dnmt3a-mutated-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/germline-variant-database-and-visualization-platform-for-bmf-and-hematologic-malignancy-predispositi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/anti-cd19-chimeric-antigen-receptor-t-cell-therapy-for-patients-with-non-hodgkins-lymphoma-and-conc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-barriers-of-autologous-hematopoietic-stem-cell-transplantation-in-newly-diagno 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-detection-of-emerging-safety-signals-in-gvhd-prophylaxis-agents-using-a-12-year-faers-slope-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/combinatorial-targeting-of-metabolic-vulnerabilities-in-t-cell-leukemia-through-nampt-inhibition 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mrd-guided-azacitidine-maintenance-improves-outcomes-in-molecularly-persistent-pediatric-core-bindin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-evaluation-of-ngs-based-mrd-detection-in-aml-using-longitudinal-matched-bone-marrow-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-younger-patients-with-chronic-lymphocytic-leukemia-treated-with-first-line-bt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-dynamic-comprehensive-geriatric-assessment-demonstrates-improvement-in-patient-fitness-after-induc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-day-non-activated-il-18-armed-car-t-cells-with-enhanced-persistence-and-durable-efficacy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allogeneic-hematopoietic-stem-cell-transplantation-for-hematological-malignancies-using-nonmyeloabla 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bone-marrow-immune-and-stromal-niche-remodeling-in-myelodysplastic-neoplasm-patients-under-erythropo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-ventoclax-initiation-prophylaxis-and-monitoring-outcomes-at-each-dose-level-and-time-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prospera-abnl-marro-002-a-randomized-phase-2-study-of-pacritinib-vs-hydroxyurea-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-levofloxacine-as-antibiotic-prophylaxis-in-mds-and-aml-patients-treated-with-azacitidi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-triplet-and-quadruplet-regimen-utilization-among-patients-with-newly-diagnosed-multiple-my 2026-08-17 monthly 0.7 https://rjrindex.com/articles/determinants-of-early-mortality-following-induction-chemotherapy-in-acute-myeloid-leukemia-experien 2026-08-17 monthly 0.7 https://rjrindex.com/articles/delta-opioid-receptor-dor-a-novel-target-for-reprogramming-tumor-associated-macrophage-tam-immu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-multiomics-reveals-molecular-identities-and-clonal-dynamics-of-mrd-progression-in-myelod 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vista-contributes-to-disease-progression-in-high-risk-myelodysplastic-syndrome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prospective-phase-iii-study-of-cd19-directed-car-t-therapy-in-relapsedrefractory-central-nervous-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bone-marrow-adipocytes-fuel-hematopoietic-regeneration-via-fatty-acid-release 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-somatic-ddx41-hot-spot-mutation-pr525h-causes-skewed-differentiation-into-plasmacytoid-dendri 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-pre-and-post-transplant-transfusion-requirements-on-outcomes-in-severe-aplastic-anemia-pa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allogeneic-hematopoietic-stem-cell-transplantation-for-myelofibrosis-patterns-treatment-and-outcom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-multicenter-study-of-brentuximab-vedotin-based-regimens-in-chinese-patients-with-relapse 2026-08-17 monthly 0.7 https://rjrindex.com/articles/supporting-routine-diagnostics-ai-for-interpretation-of-interphase-fish-images 2026-08-17 monthly 0.7 https://rjrindex.com/articles/field-level-visual-explanations-for-leukocyte-classification-using-ai-model-enhancing-interpretabil 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pharmacokinetic-pk-guided-vs-weight-based-dosing-of-hydroxyurea-for-tanzanian-children-with-sickle 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multimodal-neuroimaging-and-neurocognitive-assessment-in-adolescents-with-and-without-sickle-cell-di 2026-08-17 monthly 0.7 https://rjrindex.com/articles/explainable-ai-based-prediction-of-chronic-kidney-disease-as-a-long-term-outcome-of-sickle-cell-dise 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ihp-102-reduces-pain-and-modulates-complement-activation-in-a-sickle-cell-mouse-model 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-prospective-non-randomized-controlled-study-of-vaseline-medicated-gauze-for-topical-management-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-eif4a1-inhibitors-with-anti-tumor-activity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/notch-pathway-activation-is-mediated-by-dtx1-loss-of-function-mutations-in-dlbcl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/management-of-a-real-world-cohort-of-patients-with-paroxysmal-nocturnal-hemoglobinuria-treated-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-whole-exome-sequencing-based-genomic-profiling-of-post-transplant-lymph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/daratumumab-plus-cyclophosphamide-bortezomib-and-dexamethasone-in-newly-diagnosed-patients-with-lig 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-janus-kinase-1-and-2-inhibitor-baricitinib-for-steroid-refractory-chronic-graft-versus-hos 2026-08-17 monthly 0.7 https://rjrindex.com/articles/analysis-of-safety-and-efficacy-of-carmen-gmall-lmb-and-other-intensive-chemotherapy-combinations 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pre-transplant-minimal-residual-disease-mrd-negativity-predicts-superior-gvhd-freerelapse-free-su 2026-08-17 monthly 0.7 https://rjrindex.com/articles/social-determinants-of-health-and-emergency-department-utilization-in-sickle-cell-disease-a-systema 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cbx-663-a-novel-tcr-mimetic-t-cell-engager-targeting-a-telomerase-reverse-transcriptase-tert-pept 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-review-and-analysis-of-reported-global-blood-and-marrow-transplantation-costs-in-comparison-to-mac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cost-savings-across-bone-marrow-testing-strategies-in-persons-with-suspected-monoclonal-gammopathy-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interferon-gamma-production-in-the-bone-marrow-of-myelodysplastic-syndrome-patients-supports-a-treg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cell-free-dna-is-associated-with-central-venous-catheter-associated-deep-venous-thrombosis-in-critic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prmt1-drives-platelet-metabolic-reprogramming-thromboinflammation-and-antiplatelet-drug-resistance 2026-08-17 monthly 0.7 https://rjrindex.com/articles/btkis-and-drc-show-a-reduction-of-infections-and-need-of-hospitalization-towards-br-and-other-chemo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/estimating-the-survival-impact-of-not-receiving-car-t-cell-car-t-therapy-when-eligible-in-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fam46ctent5c-inactivation-accelerates-multiple-myeloma-progression-from-early-stages-and-remodels-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lactate-export-inhibition-reveals-a-metabolic-vulnerability-in-myelofibrosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prevalence-and-factors-associated-with-acute-transfusion-reactions-among-patients-receiving-blood-tr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/final-analysis-of-the-evaluation-of-safety-and-efficacy-of-denosumab-in-patients-with-multiple-myelo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/acute-myeloid-leukemia-eradication-targeting-cathepsin-g-with-a-dual-hla-restricted-tcr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tumor-specific-risk-of-acute-kidney-injury-a-multi-cancer-comparison-across-matched-real-world-coho 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identification-of-red-cell-distribution-width-as-a-key-predictor-of-leukemic-transformation-in-polyc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-severely-injured-civilian-trauma-patients-preemptive-transfusion-of-low-titer-group-o-non-leuko 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-impact-of-patient-personality-traits-on-adherence-to-tyrosine-kinase-inhibitor-therapy-in-patien 2026-08-17 monthly 0.7 https://rjrindex.com/articles/on-the-cellular-origins-of-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pet-imaging-biomarkers-predict-survival-in-peripheral-t-cell-lymphoma-a-systematic-review-and-meta 2026-08-17 monthly 0.7 https://rjrindex.com/articles/older-adults-with-multiple-myeloma-can-drive-car-safely 2026-08-17 monthly 0.7 https://rjrindex.com/articles/absolute-lymphocyte-count-alc-at-apheresis-and-infusion-as-a-predictor-of-safety-and-efficacy-for 2026-08-17 monthly 0.7 https://rjrindex.com/articles/azacitidine-aza-and-venetoclax-ven-combination-for-the-treatment-of-immune-mediate-inflammatory 2026-08-17 monthly 0.7 https://rjrindex.com/articles/plasmapheresis-facilitates-soluble-bcma-clearance-and-contributes-to-reversing-primary-resistance-to 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lusutrombopag-improves-platelet-engraftment-after-autologous-haematopoietic-stem-cell-transplantatio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pathological-feature-in-chronic-myeloid-leukemia-patients-with-proteinuria-receiving-olverembatinib 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comprehensive-mutational-profiling-and-clinical-outcome-of-adults-aml-with-nup98-rearrangement 2026-08-17 monthly 0.7 https://rjrindex.com/articles/continuousinfusion-cytarabine-for-leukoreduction-in-hyperleukocytic-aml-a-singlecenter-retrospect 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cpx-351-versus-venetoclax-plus-hypomethylating-agents-for-newly-diagnosed-acute-myeloid-leukemia-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-aging-and-macrophage-inhibitory-factor-mif-mediated-stromal-rewiring-drives-pre-malignant 2026-08-17 monthly 0.7 https://rjrindex.com/articles/morbidities-in-v-thalassemia-intermedia-across-the-spectrum-of-disease-severity-a-nationwide-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/weekend-admission-and-inhospital-outcomes-in-cancer-related-pulmonary-embolism-cap-a-2016-2022-n 2026-08-17 monthly 0.7 https://rjrindex.com/articles/germline-genetic-testing-uncovers-a-high-frequency-of-inborn-error-of-immunity-diagnoses-in-children 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rituximab-beats-the-odds-in-itp-a-5-year-national-showdown-against-tpo-ras 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interrogation-of-a-large-clinical-data-cohort-derived-from-a-comprehensive-panheme-ngs-based-assay-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/celmods-potently-inhibit-m-mdsc-induction-by-targeting-il-10-and-mif-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-inhibitors-positivity-on-treatment-patterns-and-disease-burden-in-chinese-patients-with-he 2026-08-17 monthly 0.7 https://rjrindex.com/articles/babesiosis-masquerading-as-itp-in-a-patient-with-cll 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-disguise-of-dyscrasia-hereditary-von-willebrand-disease-unmasked-by-mgus-associated-acquired-vw 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhancing-the-sequential-flamsa-treosulfan-conditioning-regimen-with-venetoclax-first-results-from 2026-08-17 monthly 0.7 https://rjrindex.com/articles/car-t-therapies-show-potential-benefit-as-second-line-treatment-in-relapsedrefractory-large-b-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/more-than-il-2-optimizing-feeder-free-nk-cell-function-through-cytokine-synergy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-fludarabine-exposure-on-overall-survival-in-patients-receiving-fludarabinecyclophosphamid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-using-low-dose-cyclophosphamide-fludarabine-and-thymoglobulin-in-allogen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/circulating-cd161high-cd8-t-cells-at-leukapheresis-are-associated-with-reduced-risk-of-progression-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-immunomodulatory-effects-of-irf37-transcription-factors-and-il10-in-alk-anaplastic-large-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/therapeutic-potential-of-mitochondrial-transplantation-in-the-treatment-of-mds 2026-08-17 monthly 0.7 https://rjrindex.com/articles/developing-prediction-rules-to-safely-decrease-unnecessary-head-ct-scans-for-pediatric-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cardiopulmonary-complications-of-dic-in-aml-a-nationwide-inpatient-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-2-trial-of-ai-bel-aztinterferon-a-plus-belinostat-for-htlv-1-related-adult-t-cell-leukemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cdk7-enables-adaptive-gene-transcription-required-by-stromal-cells-to-support-distinct-t-cell-lympho 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-safety-and-predictive-factors-for-response-to-glofitamab-in-chinese-patients-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bayesian-diagnostic-test-accuracy-meta-analysis-of-18f-fdg-petct-for-detecting-richters-transforma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ultra-sensitive-detection-of-clonal-m-protein-by-mass-spectrometry-enhances-detection-of-residual-di 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-daratumumab-in-treatment-of-relapsed-andor-refractory-warm-autoimmune-hemolytic-anemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-efficacy-and-diagnostic-value-of-metagenomic-next-generation-sequencing-for-pathogen-detect 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-remodeling-enables-sustained-ebv-clearance-in-b-cell-and-plasma-cell-malignancies-after-anti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clone-wars-evidence-of-clonal-stability-in-a-longitudinal-prospective-cohort-of-cancer-survivors-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cell-intrinsic-heme-synthesis-supports-glycolysis-for-activation-of-naive-cd4-t-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dynamic-biomarker-trajectories-predict-outcomes-in-aml-associated-hemophagocytic-lymphohistiocytosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/age-related-differences-in-clinical-outcomes-among-hospitalized-recipients-of-car-t-cell-therapy-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/baffr-car-t-cells-pmb-ct01-demonstrate-durable-responses-and-manageable-toxicities-in-relapsedref 2026-08-17 monthly 0.7 https://rjrindex.com/articles/presenting-features-treatment-patterns-and-predictors-of-outcomes-in-al-amyloidosis-at-a-tertirary 2026-08-17 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-red-cell-distribution-width-for-sf3b1-mutation-status-in-myelodysplastic-neoplas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-following-mrd-relapse-in-aml-patients-monitored-by-droplet-digital-pcr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-dna-repair-vulnerabilities-to-eradicate-tp53-mutated-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/daclizumab-enhances-agvhd-prophylaxis-by-modulating-t-cell-polarization-while-preserving-the-graft-v 2026-08-17 monthly 0.7 https://rjrindex.com/articles/golidocitinib-a-selective-jak1-kinase-inhibitor-in-treatment-of-late-thrombocytopenia-after-car-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/experience-with-post-transplant-cyclophosphamide-ptcy-for-gvhd-prophylaxis-in-hla-matched-related 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-features-of-flt3-internal-tandem-duplication-itd-in-acute-myeloid-leukemia-aml-patients-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/brentuximab-vedotin-plus-dhap-as-effective-salvage-therapy-in-cd30-peripheral-t-cell-lymphoma-a-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-scope-trial-a-phase-2-study-of-selinexor-in-combination-with-pomalidomide-and-dexamethasone-for 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhancing-hemostasis-in-glanzmann-thrombasthenia-via-protein-s-inhibition 2026-08-17 monthly 0.7 https://rjrindex.com/articles/modeling-of-a-hyper-inflammatory-hematopoietic-niche-ex-vivo-reveals-a-multi-step-process-driving-ca 2026-08-17 monthly 0.7 https://rjrindex.com/articles/glofitamab-combined-with-salvage-therapy-for-relapsed-or-refractory-aggressive-b-cell-lymphomas-eff 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ixazomib-combined-with-daratumumab-based-regimens-as-first-line-therapy-for-transplant-ineligible-pa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nationwide-and-regional-trends-outcomes-and-cost-of-systemic-thrombolysisstandard-catheter-direct 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tcr-t-cells-targeting-a-public-neoantigen-produced-by-the-sf3b1-k700e-mutation-kill-sf3b1-mutant-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-safety-of-polatuzumab-vedotin-combined-with-zuberitamab-plus-cyclophosphamide-dox 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multidimensional-profiling-of-dendritic-cell-and-monocyte-subsets-in-sickle-cell-anemia-correlation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/access-to-acute-promyelocytic-leukemia-treatment-in-new-york-city 2026-08-17 monthly 0.7 https://rjrindex.com/articles/construction-of-a-prognostic-model-for-new-diffuse-large-b-cell-lymphoma-and-research-on-risk-factor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-new-model-for-predicting-occult-cancer-after-unprovoked-vte-and-its 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tumor-derived-microrna-125a-impairs-cart-cell-function-and-predicts-treatment-failure-in-b-cell-mali 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pyruvate-kinase-deficiency-is-associated-with-mitochondrial-retention-decreased-antioxidant-and-hif 2026-08-17 monthly 0.7 https://rjrindex.com/articles/zanubrutinib-obinutuzumab-sonrotoclax-in-patients-with-treatment-naive-chronic-lymphocytic-leuke 2026-08-17 monthly 0.7 https://rjrindex.com/articles/oral-iptacopan-monotherapy-demonstrates-clinically-meaningful-hemoglobin-increases-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identifying-treatment-response-in-aml-through-a-multi-omics-classifier-of-malignant-cell-states 2026-08-17 monthly 0.7 https://rjrindex.com/articles/xpo1-inhibition-by-selinexor-blocks-nucleo-cytoplasmic-trafficking-of-multiple-members-of-the-nf-kb 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hetrombopag-for-patients-with-persistent-primary-immune-thrombocytopenia-a-post-hoc-analysis-of-a-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/time-to-third-line-treatment-after-bendamustine-rituximab-with-or-without-acalabrutinib-in-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/elranatamab-for-relapsedrefractory-multiple-myeloma-multi-centre-real-world-outcomes-from-the-uni 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-analysis-of-a-phase-2b-randomized-active-control-study-of-flonoltinib-maleate-fm-vs 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unequal-outcomes-the-role-of-institutional-setting-in-the-management-of-primary-cns-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-of-infectious-complications-in-acute-myeloid-leukemia-patients-undergoing-induction-chemot 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patient-characteristics-and-treatment-outcomes-with-pola-r-chp-a-real-world-study-of-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-thymic-stromal-lymphopoietin-tslp-as-a-biomarker-in-acute-graft-versus-host-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/major-adverse-cardiovascular-events-after-teclistamab-in-relapsed-refractory-multiple-myeloma-a-mul 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nivolumab-and-pembrolizumab-in-treatment-of-relapsed-or-refractory-classical-hodgkin-lymphoma-syste 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epidemiology-and-outcomes-of-rosai-dorfman-destombes-disease-rdd-a-ten-year-single-center-real-wo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deep-learning-based-image-analysis-of-pretreatment-fdg-petct-predicts-car-t-cell-treatment-outcome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-from-the-randomized-double-blind-placebo-pbo-controlled-phase-3-imerge-trial 2026-08-17 monthly 0.7 https://rjrindex.com/articles/this-is-a-title-in-sentence-casesynnotch-cd123-and-cll1-car-t-can-specifically-target-aml-to-avoid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-based-minimal-residual-disease-assessment-predicts-progression-free-survival-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-in-human-trial-of-allogeneic-cd6-car-tregs-in-patients-with-chronic-graft-versus-host-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/overcoming-leukemia-stem-cells-via-targeting-akt-wntv-catenin-by-ai-powered-mrna-delivery-of-peptid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/promote-fl-pirtobrutinib-and-mosunetuzumab-to-enhance-treatment-efficacy-for-patients-with-relapsed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/toward-n-of-one-gene-therapies-scalable-ex-vivo-adenine-base-editing-via-lipid-nanoparticles-in-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-cd3xcd20-bispecific-antibody-for-the-treatment-of-primary-and-secondary-centr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/leveraging-novel-cd38-targeted-antibody-drug-conjugates-for-the-treatment-of-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/direct-hemoglobin-s-polymerization-inhibitor-mcp435-completely-halts-ongoing-disease-pathophysiology 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effect-of-flt3-maintenance-in-older-flt3-itd-adults-undergoing-allogeneic-hct-a-post-hoc-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interim-results-of-a-quality-improvement-study-evaluating-subjective-and-objective-sleep-quality-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/luspatercept-combined-with-immunosuppressive-therapy-reduces-inflammation-in-aplastic-anemia-by-inhi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chidamide-in-combination-with-brentuximab-vedotin-for-cd30-peripheral-t-cell-lymphoma-in-patients-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pharmacological-inhibition-of-polrmt-mimicking-polrmt-rare-variants-associated-with-sideroblastic-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-multiple-myeloma-mm-patients-with-del-17p-as-a-sole-high-risk-cytogenetic-abnormality 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-loop-structured-cd19cd22-dual-targeting-car-t-therapy-for-patients-with-refractoryrelapsed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lipid-nanoparticle-mediated-mrna-transfection-enables-efficient-and-safe-generation-of-car-macrophag 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effectiveness-of-sirolimus-for-pediatric-autoimmune-cytopenias-and-factors-associated-with-clinical 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patients-with-immune-thrombocytopenia-and-antiplatelet-antibodies-show-increased-platelet-activation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-the-risk-of-non-melanoma-skin-cancer-in-patients-with-porphyria-cutanea-tarda-a-retrospe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effects-of-serum-vitamin-d-on-platelet-function-in-primary-immune-thrombocytopenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-survival-outcomes-following-allogeneic-hematopoietic-cell-transplantation-in-peripheral-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/serum-bcma-sbcma-levels-in-plasma-cell-dyscrasias-insights-from-a-south-indian-prospective-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reassessing-pre-chemotherapy-laboratory-testing-in-r-chop-are-we-doing-too-much 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-of-bleeding-in-15495-patients-with-myeloproliferative-neoplasms-by-treatment-type-and-thrombot 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ampk-agonism-improves-in-vivo-car-t-cell-function-across-a-range-of-platforms-and-clinical-indicatio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/attention-based-multiple-instance-learning-predicts-car-t-cell-therapy-outcomes-from-infusion-produc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/signaling-role-of-viral-protein-motif-and-its-application-in-car-t-cell-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/stimulated-car-t-cells-from-non-hodgkin-lymphomas-patients-engage-and-activate-monocytes-via-extrace 2026-08-17 monthly 0.7 https://rjrindex.com/articles/absence-of-lymphocytosis-after-starting-treatment-with-cbtki-is-a-rare-phenomenon-except-for-cd49d-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeted-capture-sequencing-identifies-driver-mutations-and-enables-prognostic-modeling-in-multiple 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tumor-induced-dendritic-cell-dysfunction-impairs-t-cell-proliferation-and-confers-poor-prognosis-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epcoritamab-with-lenalidomide-and-tafasitamab-in-patients-with-relapsedrefractory-diffuse-large-b-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/combination-anti-pd1-antibody-and-rituximab-followed-by-r-chop-for-newly-diagnosed-dlbcl-in-elderly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fibrinogen-concentrate-versus-cryoprecipitate-for-bleeding-in-cardiac-surgery-patients-stratified-by 2026-08-17 monthly 0.7 https://rjrindex.com/articles/response-to-tfpi-inhibition-in-severe-factor-v-deficiency-with-a-novel-compound-heterozygous-mutatio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ivosidenib-in-refractory-or-relapsed-idh1-mutated-acute-myeloid-leukemia-patients-in-real-life-setti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-fertility-outcome-in-a-cohort-of-scd-patients-undergoing-haploidentical-allogeneic-stem-cell-tra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/maintenance-therapy-in-aml-a-meta-analysis-and-a-single-center-retrospective-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-risk-of-major-adverse-cardiovascular-events-in-polycythemia-vera-patients-treated-with-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/next-day-manufactured-cd19-car-t-cells-exhibit-superior-persistence-compared-to-conventional-car-t-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimizing-eln-2022-developing-and-validating-a-dynamic-prognostic-model-for-aml-using-platelet-cha 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-survival-cognitive-and-health-related-quality-of-life-outcomes-of-methotrexateifosfamid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-of-social-determinants-of-health-sdoh-with-clinic-visit-adherence-healthcare-utilizat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identification-of-dynamic-markers-for-multiple-myeloma-in-patients-with-mgus-and-t2dm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/short-term-blinatumomab-regimen-in-newly-diagnosed-induction-and-mrd-negative-consolidation-treatmen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immunological-responses-to-blinatumomab-treatment-in-b-acute-lymphoblastic-leukaemia-b-all-patient 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dna-methylation-variability-in-pediatric-aplastic-anemia-contributes-to-t-cell-differentiation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-reverse-vaccinology-approach-to-development-a-multi-epitope-vaccine-candidate-against-multiple-mye 2026-08-17 monthly 0.7 https://rjrindex.com/articles/secondary-hlh-a-complication-of-anaplasmosis-infection 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gut-microbiome-structure-prior-to-neoadjuvant-chemoradiotherapy-predicts-risk-of-myelosuppression-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-of-duffy-antigen-receptor-for-chemokines-with-clinical-conditions-a-scoping-review 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-case-of-delayed-transformation-to-lymphoid-blast-crisis-in-a-patient-with-chronic-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/research-on-allogeneic-car-tbite-cells-targeting-cll-1siglec-6-for-the-treatment-of-acute-myeloid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-from-multiple-myeloma-in-patients-younger-than-55-years-of-age-in-the-united-sta 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-flow-cytometry-fc-and-next-generation-sequencing-ngs-for-assessing-minimal-residual-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/simvastatin-targets-the-cholesterol-bile-acid-axis-to-improve-all-survival-by-remodeling-the-metabol 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immunophenotypic-identification-of-etp-like-t-all-using-cd1a-cd165-and-cd184 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-stage-nodular-lymphocyte-predominant-hodgkin-lymphoma-disease-characteristics-treatment-patt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interim-results-from-a-multicenter-trial-assessing-the-clinical-relevance-of-copy-number-aberrations 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-of-heart-failure-in-patients-with-acute-myeloid-leukemia-who-received-daunorubicin-versus 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hnrnpk-haploinsufficiency-in-del9q-acute-myeloid-leukemia-reveals-targetable-vulnerabilities 2026-08-17 monthly 0.7 https://rjrindex.com/articles/once-weekly-carfilzomib-56-mgm2-pomalidomide-and-dexamethasone-k56pd-in-patients-with-first-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/convergence-in-age-adjusted-mortality-rates-and-proportion-of-all-deaths-from-covid-19-among-patient 2026-08-17 monthly 0.7 https://rjrindex.com/articles/myc-rearrangements-with-immunoglobulin-genes-as-an-independent-prognostic-factor-of-progression-free 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcome-of-children-and-adolescents-with-newly-diagnosed-t-cell-acute-lymphoblastic-leukemia-result 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-patient-preferences-for-chronic-lymphocytic-leukemia-cll-in-korea-a-discrete-choice-ex 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-comparing-the-use-of-glp-1-receptor-agonists-in-patients-with-cml-and-comorbid-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrating-palliative-care-for-adolescents-and-young-adults-with-hematologic-malignancies-insights 2026-08-17 monthly 0.7 https://rjrindex.com/articles/toward-precision-pathology-deep-learning-supported-fibrosis-grading-augments-performance-of-interna 2026-08-17 monthly 0.7 https://rjrindex.com/articles/therapeutic-effect-of-menin-inhibitors-is-reversible-in-aml-treatment-and-could-be-enhanced-by-the-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multicenter-randomized-phase-ii-study-of-epcoritamab-for-patients-with-large-b-cell-lymphomas-achie 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dynamic-deasix-score-is-a-robust-predictor-of-survival-and-relapse-after-allogeneic-hematopoietic-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/recent-trends-in-the-management-of-relapsingrefractory-diffuse-large-b-cell-lymphoma-a-systematic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/do-ssris-increase-bruising-a-propensity-matched-proxy-analysis-using-generalized-anxietydepression 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-utilization-of-bispecific-antibodies-for-treatment-of-diffuse-large-b-cell-lymphoma-dlbc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-bmetl-regimen-orelabrutinib-plus-semustine-temozolomide-and-lenalidomide-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/etoposide-cytarabine-pegfilgrastim-vs-cyclophosphamide-granulocyte-colony-stimulating-factor-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bleeding-rates-in-patients-with-congenital-hemophilia-b-without-inhibitors-a-systematic-review-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-safety-and-feasibility-of-a-venetoclax-augmented-treosulfan-based-reduced-intensi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treosulfan-based-vs-busulfan-based-conditioning-for-hematopoietic-stem-cell-transplantation-a-syst 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tailored-prophylaxis-in-severe-hemophilia-a-real-world-experience-with-efanesoctocog-alfa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-i-study-of-autologous-cd5-knockout-anti-cd5-car-t-cells-in-cd5-hematologic-mal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unveiling-the-second-wave-viral-triggered-biphasic-car-t-expansion-drives-late-onset-iec-hs-char 2026-08-17 monthly 0.7 https://rjrindex.com/articles/iqgap1-is-a-novel-non-degraded-substrate-of-celmods-and-involved-in-trafficking-of-immune-cells-to-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-machine-learning-ml-and-traditional-statistical-techniques-in-survival-analysis-of-real-worl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-feasibility-of-collecting-social-determinants-of-health-in-the-national-multi-center-grasp-sickl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cytoplasmic-but-not-nuclear-cleaved-gsdmd-expression-in-live-macrophages-and-dlbcl-cells-marks-proin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patients-with-burkitts-lymphoma-have-a-better-survival-probability-if-treated-in-an-academic-cancer 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unpredictability-of-caregiver-gaps-in-multiple-myeloma-results-from-a-survey-of-ampgt1000-patien 2026-08-17 monthly 0.7 https://rjrindex.com/articles/who-participates-in-myeloma-trials-clinical-and-geographic-predictors-of-access-and-outcomes-in-bri 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-retrospective-quality-improvement-review-of-cryoprecipitate-overuse-in-a-community-hospital 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-immune-reconstitution-and-final-1-year-follow-up-after-fixed-duration-venetoclax-obinutuzu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-study-of-hetrombopag-vs-eltrombopag-in-promoting-platelet-engraftment-post-autologous-h 2026-08-17 monthly 0.7 https://rjrindex.com/articles/microbiota-metabolite-phenlyacetylglycine-alleviates-acute-graft-versus-host-diseases 2026-08-17 monthly 0.7 https://rjrindex.com/articles/idiopathic-neutropenia-after-clonal-and-antigenic-exclusion-a-progesterone-dependent-subtype 2026-08-17 monthly 0.7 https://rjrindex.com/articles/beyond-complement-patient-and-in-vitro-evidence-for-alternative-mechanisms-of-monocyte-platelet-agg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/autologous-and-allogeneic-stem-cell-transplantation-for-alk-positive-anaplastic-large-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/alterations-in-the-gut-microbiome-and-the-association-of-butyrate-producers-with-progression-free-su 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-fatty-acid-binding-protein-5-inhibitors-sbfi103-and-sbfi1143-impede-myeloma-cell-fitness 2026-08-17 monthly 0.7 https://rjrindex.com/articles/understanding-access-and-treatment-challenges-in-multiple-myeloma-care 2026-08-17 monthly 0.7 https://rjrindex.com/articles/all-trans-retinoic-acid-for-refractory-cancer-therapy-induced-thrombocytopenia-a-new-option-beyond 2026-08-17 monthly 0.7 https://rjrindex.com/articles/complement-activation-profile-in-primary-immune-thrombocytopenia-its-association-with-pa-igm-incre 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multi-centre-real-world-outcome-of-patients-with-richter-transformation-receiving-cd19-directed-comm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/azin1tecr-reprograms-fatty-acid-metabolism-to-drive-acute-myeloid-leukemia-progression 2026-08-17 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-immunoinflammatory-phenotypes-predict-survival-in-latin-american-patients-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterization-of-sickle-cell-disease-associated-organ-dysfunction-in-aged-townes-hbss-mice-and-ef 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phosphorylation-induced-structural-remodeling-of-band-3-as-a-driver-of-metabolic-dysfunction-in-sick 2026-08-17 monthly 0.7 https://rjrindex.com/articles/graft-vs-host-disease-outcomes-in-early-tacrolimus-withdrawal-following-allogeneic-hematopoietic-ste 2026-08-17 monthly 0.7 https://rjrindex.com/articles/selective-par1-activation-mitigates-pain-and-neuroinflammatory-markers-in-a-murine-model-of-sickle-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-intensity-may-alter-the-prognostic-impact-of-baseline-co-mutations-in-newly-diagnosed-flt3 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unmasking-myeloid-sarcoma-a-seer-database-study-of-an-underrecognized-malignancy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-myc-alterations-in-de-novo-large-b-cell-lymphoma-an-italian-single-center-experience 2026-08-17 monthly 0.7 https://rjrindex.com/articles/myelofibrosis-stem-cell-fitness-requires-microenvironmental-cell-interactions 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thymopoiesis-as-a-biomarker-of-cancer-risk-and-outcome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prevalence-and-mortality-of-infections-following-car-t-cell-therapy-in-children-adolescents-and-yo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-with-dasatinib-in-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia-a-systemat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/germline-sept6-mutations-in-congenital-neutropenia-and-myelodysplastic-syndrome-induce-de-novo-prote 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-319-a-cd3xcd19-t-cell-engager-monotherapy-for-patients-with-refractoryrelapsed-b-cell-acute-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/breaking-geographic-barriers-in-a-mexican-ambulatory-transplant-program-early-outcomes-in-a-diverse 2026-08-17 monthly 0.7 https://rjrindex.com/articles/understanding-patient-preferences-for-treatment-of-acute-leukemia-in-the-unites-states-a-discrete-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/burden-of-immune-thrombocytopenia-in-hospitalized-myeloid-leukemia-patients-analysis-from-a-nationa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effectiveness-of-epcoritamab-in-a-heterogeneous-population-with-relapsedrefractory-rr-diffuse-la 2026-08-17 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-forecast-of-cardiovascular-mortality-in-non-hodgkin-lymphoma-patients-in-the-uni 2026-08-17 monthly 0.7 https://rjrindex.com/articles/antiplatelet-therapy-in-anticoagulated-cirrhotic-patients-with-chronic-portal-vein-thrombosis-a-ret 2026-08-17 monthly 0.7 https://rjrindex.com/articles/perturbation-of-inkt-differentiation-during-clonal-hematopoiesis-from-rewiring-of-inflammation-and-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-crispr-screen-in-enucleated-human-red-cells-identifies-clic3-and-vamp8-as-critical-regulators-of-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-a-novel-prognostic-assessment-model-for-high-risk-acute-promyelocytic-leukem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/harnessing-bcl2-inhibition-with-btk-inhibition-in-follicular-lymphoma-a-translational-trial-with-me 2026-08-17 monthly 0.7 https://rjrindex.com/articles/son-haploinsufficiency-in-hematopoietic-cells-disrupts-the-crosstalk-between-splicing-fidelity-and-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-and-symptom-burden-of-patients-with-vexas-real-world-data-from-a-mul 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-and-cytogenetic-landscape-of-black-patients-with-myelodysplastic-syndrome-in-the-veterans 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dara-vd-vs-vrd-a-breakthrough-in-newly-diagnosed-multiple-myeloma-treatment-superior-survival-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prospective-clinical-study-on-the-efficacy-and-safety-of-the-dciax-regimen-in-treating-relapsedref 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-monotherapy-and-combination-usage-of-mogamulizumab-among-patients-with-mycosis-fungoides 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-role-of-fdg-pet-in-outcomes-of-relapsedrefractory-large-b-cell-lymphoma-treated-with-cd3 2026-08-17 monthly 0.7 https://rjrindex.com/articles/psf3-recruits-dna-polymerase-theta-polth-to-stalled-replication-forks-to-promote-dna-repair-and-sur 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unique-nk-like-t-cell-population-identified-in-uba1mt-cells-in-vexas-associated-with-il-8-mediated-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-tickborne-infection-associated-hemophagocytic-lymphohistiocytosis-treated-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-central-nervous-system-relapse-after-b-acute-lymphoblastic-leukemia-a-child 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcome-of-low-frequency-outpatient-monitoring-for-venetoclax-initiation-in-cll-single-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effect-of-gvhd-prophylaxis-on-renal-function-and-survival-outcomes-in-allogeneic-hematopoietic-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-diagnostic-pivot-paroxysmal-nocturnal-hemoglobinuria-mimicking-refractory-immune-thrombocytopenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disparities-and-reversal-of-declines-a-22-year-analysis-of-mortality-trends-in-patients-with-concur 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-long-non-coding-rna-wt1-as-controls-differentiation-programs-and-leukemic-cell-fate-in-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/palliative-care-consultation-reduces-hospital-costs-and-length-of-stay-among-decedents-with-hematolo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/autologous-stem-cell-transplantation-and-real-world-outcomes-in-angioimmunoblastic-t-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sequence-based-artificial-intelligence-guided-inhibitory-peptides-to-counteract-aav-neutralizing-ant 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unveiling-flt3-in-b-all-molecular-drivers-and-targeted-treatment-opportunities 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrated-analysis-of-autoantibody-profiles-and-clonal-distribution-of-ras-mutations-in-juvenile-my 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-gvhd-outcomes-after-chemotherapy-only-conditioning-in-nicotinamide-expanded-umbilical-cor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-impact-of-environmental-air-exposues-on-disease-characteristics-and-outcomes-in-a-cohort-of-pati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-requiring-paroxysmal-nocturnal-hemoglobinuria-in-association-with-myeloproliferative-neopl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-psychometric-properties-of-the-stoplight-pain-scale-in-children-with-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reduction-of-iron-overload-in-hereditary-hemochromatosis-model-mice-by-presence-of-iron-metabolism-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phytosphingosine-alleviates-acute-gvhd-by-inducing-th-cell-differentiation-to-tr1-through-gpr120il 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-fructose-diet-exacerbates-acute-gvhd-through-microbiota-dysbiosis-and-hif-1a-mediated-macrophag 2026-08-17 monthly 0.7 https://rjrindex.com/articles/car-hematotox-score-for-predicting-outcomes-among-myeloma-patients-receiving-bcma-targeting-cart-con 2026-08-17 monthly 0.7 https://rjrindex.com/articles/equecabtagene-autoleucel-in-patients-with-relapsed-or-refractory-multiple-myeloma-the-first-real-wo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chronic-myeloid-leukaemia-in-the-pregnancy-experience-at-a-university-hospital-in-paraguay 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-in-adult-aml-with-kmt2a-rearrangements-a-comparative-analysis-with-rr-kmt2ar-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gt919-a-novel-ikzf31-molecular-glue-degrader-phase-1-safety-and-preliminary-efficacy-in-relapsed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-previous-bcma-exposure-evidence-from-practice-outside-of-clinical-trials-to-inform-talque 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-dissection-of-pathogenic-t-cell-response-to-tacrolimus-in-immune-thrombocytopenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-safety-and-efficacy-of-aponermin-and-daratumumab-based-regimens-in-patients-with-multiple 2026-08-17 monthly 0.7 https://rjrindex.com/articles/selinexor-combined-with-pegaspargase-and-dexamethasone-followed-by-radiotherapy-for-newly-diagnose 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-selection-and-functional-outcomes-in-treatment-related-acute-myeloid-leukemia-taml-and-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/antibiotic-risk-score-for-acute-graft-versus-host-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/behavioral-health-and-biophysical-complexity-as-predictors-of-healthcare-utilization-in-adults-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-expression-of-gfp-on-hematopoietic-stem-cells-acts-as-a-neoantigen-triggering-increased-t-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/examining-the-utility-of-rbc-transfusions-in-uncomplicated-vaso-occlusive-episodes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-and-machine-learning-applications-in-iron-deficiency-anemia-a-systematic-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/socioeconomic-disparities-in-the-receipt-of-allogeneic-stem-cell-transplantation-among-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chronic-opioid-medication-use-is-associated-with-healthcare-utilization-and-fatigue-in-adults-with-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/increased-risk-of-venous-thromboembolism-and-hypertensive-disorders-during-pregnancy-in-sickle-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcome-and-recovery-trajectories-for-intracerebral-hemorrhage-in-adults-with-primary-immune-thrombo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/de-novo-secondary-central-nervous-system-lymphoma-a-real-world-cohort-study-over-two-decades 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-of-lumbar-puncture-in-adult-patients-with-acute-lymphoblastic-leukemia-and-thrombocytopenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ezh2-inactivation-cooperates-with-hoxa9-to-induce-leukemic-transformation-of-human-t-cell-progenitor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-post-relapse-survival-outcomes-in-children-with-acute-myeloid-leukemia-by-race-and-ethnic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-mammalian-protein-based-coacervate-platform-enables-scalable-engineering-for-car-t-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pericapsular-nerve-block-and-ablation-as-a-novel-pain-modifying-strategy-in-sickle-cell-patients-wih 2026-08-17 monthly 0.7 https://rjrindex.com/articles/selective-degradation-of-oncogenic-signaling-nodes-by-momelotinib-based-protacs-exerts-potent-anti-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/baseline-characterization-of-nutrition-counseling-and-modifiable-cardiovascular-risk-factors-among-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-frontline-blinatumomab-in-children-with-standard-risk-b-cell-acute-lymphoblast 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-mayo-stage-iiib-systemic-al-amyloidosis-treated-with-daratumumab-based-fro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chorionic-villus-sampling-acceptability-and-therapeutic-abortion-compliance-in-beta-thalassemia-mino 2026-08-17 monthly 0.7 https://rjrindex.com/articles/national-trends-in-deep-vein-thrombosis-dvt-hospitalizations-comparing-in-hospital-outcomes-in-pa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cardioprotection-without-risk-meta-analysis-of-prophylactic-agents-in-low-risk-cancer-patients-on-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-thrombocytopenia-on-hemorrhage-and-recurrent-thrombosis-in-patients-with-cancer-associated 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immunogenicity-assessment-of-concizumab-in-patients-with-hemophilia-a-and-b-assays-developed-to-mea 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pre-transplant-physical-function-and-sarcopenia-assessment-in-allogeneic-stem-cell-transplant-recipi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/zanubrutinib-venetoclax-for-treatment-naive-chronic-lymphocytic-leukemiasmall-lymphocytic-lymphom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cdk46-inhibition-mitigates-chemotherapy-induced-expansion-of-tp53-mutant-clonal-hematopoiesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-in-us-chronic-lymphocytic-leukemia-clinical-trial-enrollment-a-part 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transitioning-from-fish-to-ngs-for-immunoglobulin-translocation-detection-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interim-report-of-a-phase-12-study-of-esg206-in-patients-with-refractory-or-relapsed-primary-immune 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transfusion-independence-with-momelotinib-regardless-of-baseline-erythropoietin-levels-in-the-phase 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ex-vivo-expanded-adaptive-nk-cells-in-combination-with-a-bispecific-nk-cell-engager-targeting-bcma-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/endothelial-cell-derived-mitochondrial-transfer-to-acute-myeloid-leukemia-alters-global-gene-express 2026-08-17 monthly 0.7 https://rjrindex.com/articles/germline-mediated-hr-deficiency-alu-element-duplication-and-immune-pathway-alterations-define-aggr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-a-novel-cd19bcma-dual-car-t-for-autoimmune-diseases 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimising-mrd-guided-treatment-umrd4-as-a-half-way-treatment-timepoint-for-ibrutinib-venetoclax-su 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-r-minichop-versus-r-chop-in-older-patients-with-diffuse-large-b-cell-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/retrospective-evaluation-of-the-g8-score-in-cll-patients-treated-with-targeted-therapies-a-single-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/carma-1-the-phase-i-study-of-senl101-a-naturally-selected-nanobody-based-cd7-car-t-therapy-in-rel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clonal-architecture-and-dynamics-of-somatic-evolution-in-aplastic-anemia-and-paroxysmal-nocturnal-he 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genomic-determinants-of-treatment-outcome-and-identification-of-a-new-genomic-subset-of-adult-acute 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interim-and-end-of-treatment-fdg-pet-demonstrate-limited-ability-to-predict-3-year-progression-free 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preclinical-activity-of-investigational-menin-inhibitor-dsp-5336-enzomenib-based-combinations-agai 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clearance-of-ras-pathway-mutations-prior-to-allogeneic-transplant-in-acute-myeloid-leukemia-are-asso 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-risk-of-bleeding-following-car-t-cell-therapy-insights-from-the-dutch-follow-that-car-regis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-anti-bcma-car-t-in-brazil-a-single-center-retrospective-case-series 2026-08-17 monthly 0.7 https://rjrindex.com/articles/external-validation-of-ttp-14-a-novel-machine-learning-model-that-improves-rapid-diagnosis-of-immun 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interim-pet-adapted-de-escalation-chemotherapy-regimen-for-advanced-stage-classical-hodgkin-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/luspatercept-initiated-at-the-maximum-approved-dose-in-transfusion-dependent-lower-risk-myelodysplas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-international-diamond-blackfan-anemia-syndrome-cancer-consortium-preliminary-results 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cerebral-and-peripheral-microvascular-function-in-sickle-cell-disease-blood-flow-and-oxygen-extract 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prospective-assessment-of-measurable-residual-disease-kinetics-in-intensively-treated-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-car-t-infusion-during-front-line-consolidation-induces-deep-and-sustained-remission-in-newly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-quintessential-2-a-phase-3-study-of-arlocabtagene-autoleucel-versus-standard-of-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-with-elranatamab-in-multiple-myeloma-a-multi-center-analysis-from-the-united-st 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tumor-clearance-t-cell-fitness-and-minimal-residual-disease-mrd-outcomes-in-patients-with-relaps 2026-08-17 monthly 0.7 https://rjrindex.com/articles/selinexor-mezigdomide-and-dexamethasone-in-patients-with-relapsedrefractory-multiple-myeloma-who 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-autologous-cd19-directed-car-t-cell-therapy-in-relapsedrefractory-large-b-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-2-open-label-study-of-the-safety-tolerability-pharmacokinetics-pharmacodynamics-and-eff 2026-08-17 monthly 0.7 https://rjrindex.com/articles/car-t-cell-therapy-in-multiple-myeloma-in-a-front-line-setting-a-systematic-review-and-meta-analysi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/low-dose-teclistamab-in-newly-diagnosed-multiple-myeloma-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/vhydroxybutyrate-metabolism-enhances-car-t-cell-function-via-transcriptional-and-epigenetic-reprogr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-bispecific-t-cell-engagers-in-plasma-cell-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-real-world-safety-and-efficacy-of-bcma-directed-chimeric-antigen-receptor-t-cell-therapy-in-syst 2026-08-17 monthly 0.7 https://rjrindex.com/articles/etnk1-mutations-define-a-distinct-subset-of-myeloid-neoplasms-with-unique-cytogenetic-and-molecular 2026-08-17 monthly 0.7 https://rjrindex.com/articles/engineered-extracellular-vesicles-for-in-vivo-gene-therapy-in-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/assessing-the-cost-amp-cost-effectiveness-of-next-generation-sequencing-for-the-diagnosis-of-hemat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/utilization-and-cost-trends-of-topical-mechlorethamine-for-cutaneous-t-cell-lymphoma-in-the-united-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/random-survival-forest-improves-prediction-of-overall-mortality-among-dlbcl-patients-against-convent 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-novel-allosteric-nek7-inhibit-ofirnoflast-ht-6184-reduces-oxidized-mitochondrial-dna-in-patien 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ls1781-arm-e-phase-ii-clinical-trial-to-assess-the-safety-and-efficacy-of-high-dose-iv-ascorbic-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pilot-of-standardized-cognitive-behavioral-therapy-for-young-adults-with-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd1922-car-t-cells-in-children-and-young-adults-with-b-all-final-phase-1-trial-results 2026-08-17 monthly 0.7 https://rjrindex.com/articles/obecabtagene-autoleucel-obe-cel-a-cd19-targeting-chimeric-antigen-receptor-car-t-cell-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inhibition-of-telomerase-and-alt-pathways-in-mdsaml-cell-lines 2026-08-17 monthly 0.7 https://rjrindex.com/articles/challenges-in-comparing-outcomes-of-frontline-clinical-trials-for-diffuse-large-b-cell-lymphoma-pati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-baseline-metabolic-tumor-volume-from-lysa-ro-chop-trial-inpatients-with-previous 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-prognostic-factors-in-aml-patients-undergoing-second-allogeneic-hematopoietic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-novel-agents-in-the-treatment-of-acute-myeloid-leukemia-and-myelodysplastic-syndrome-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparison-of-axi-cel-versus-liso-cel-as-2nd-line-therapy-for-relapsedrefractory-large-b-cell-lymph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-oral-eicosapentaenoic-acid-on-veno-occlusive-diseasesinusoidal-obstruction-syndrome-onset 2026-08-17 monthly 0.7 https://rjrindex.com/articles/expansion-differentiation-and-culture-of-hematopoietic-stem-amp-progenitor-cells-using-an-ancill 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-ubiquitin-specific-protease-usp-network-regulates-wntv-catenin-activity-in-myeloid-leukemia-cel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/involvement-of-bone-marrow-liver-spleen-and-extranodal-number-were-associated-with-poor-outcome-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/operational-efficiencies-and-cost-savings-of-using-one-bispecific-antibody-fda-approved-for-both-rr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-morbidity-and-early-readmissions-in-thrombotic-thrombocytopenic-purpura-requiring-intensive-car 2026-08-17 monthly 0.7 https://rjrindex.com/articles/redefining-what-on-hydroxyurea-means 2026-08-17 monthly 0.7 https://rjrindex.com/articles/temporal-multiomic-profiling-reveals-intrinsic-resistance-mechanisms-to-erk-inhibition-in-relapsed-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/platelets-modulate-the-cd4-t-cell-immune-response-during-immune-thrombocytopenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/health-state-utility-values-in-congenital-thrombotic-thrombocytopenic-purpura-cttp-a-vignette-bas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-azacitidine-venetoclax-combined-with-gha-priming-regimen-in-the-treatment-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lipid-deregulation-impacts-hematopoietic-stem-cell-functions-during-aging 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-combined-with-cacag-regimen-as-a-bridge-to-allogeneic-hematopoietic-stem-cell-transplanta 2026-08-17 monthly 0.7 https://rjrindex.com/articles/quantifying-disparity-race-socioeconomic-status-and-survival-disparities-in-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/stroke-in-adults-with-sickle-cell-disease-outcomes-of-a-non-hbs-targeted-combined-hydroxyurea-and-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-single-center-retrospective-study-of-golidocitinib-for-the-treatment-of-peripheral-t-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-i-dose-finding-study-of-mogamulizumab-in-combination-with-brentuximab-vedotin-in-previously 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allogeneic-hematopoietic-stem-cell-transplantation-for-acute-leukemias-of-mixed-or-ambiguous-lineage 2026-08-17 monthly 0.7 https://rjrindex.com/articles/caplacizumab-as-a-single-agent-without-plasma-exchange-in-relapsed-and-refractory-thrombotic-thrombo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improvement-in-kidney-function-after-12-months-of-voxelotor-in-sickle-cell-disease-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-patients-with-idh1idh2-mutated-clonal-hematopoiesis-a-single-center-retrospec 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-pre-existing-central-nervous-system-conditions-and-cognitive-impairments-on-toxicity-and-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/validation-of-the-high-risk-consensus-genomic-staging-system-in-the-era-of-bispecific-antibodies-ro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/timed-inhibition-of-the-sting-pathway-improves-tissue-regeneration-and-prevents-gvhd-following-allo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/independent-international-validation-of-the-unsupervised-harmony-classification-of-acute-myeloid-le 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transcriptomic-subclasses-of-kmt2a-and-nup98-gene-fusions-in-adolescent-and-adult-acute-myeloid-leuk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/factors-influencing-patient-treatment-selection-among-bispecific-antibodies-for-relapsedrefractory 2026-08-17 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-remote-healthcare-utilization-in-mm-patients-undergoing-autologous-stem-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trials-in-progress-a-phase-ib-trial-of-epcoritamab-in-combination-with-ibrutinib-in-relapsed-or-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/maribavir-for-cytomegalovirus-infections-after-hematopoietic-stem-cell-transplantation-a-real-world 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pharmacological-cd206-blocking-attenuates-cell-free-hemoglobin-induced-liver-damage-in-sickle-cell-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mechanisms-of-chemotherapy-resistance-driven-by-mecom-overexpression 2026-08-17 monthly 0.7 https://rjrindex.com/articles/building-a-kenyan-framework-for-advanced-multiple-myeloma-care-outcomes-from-the-2024-national-work 2026-08-17 monthly 0.7 https://rjrindex.com/articles/contemporary-survival-trends-in-patients-with-adult-t-cell-leukemialymphoma-atll-in-the-united-st 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dna-methylation-profiling-identifies-two-epigenetic-subgroups-with-prognostic-implications-in-pediat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/blinatumomab-following-reduced-intensity-induction-chemotherapy-in-chinese-children-with-intermediat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-outcomes-in-patients-with-myelofibrosis-treated-with-pacritinib-following-a-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thrombocytosis-drives-alteration-of-primary-hemostasis-and-acquired-von-willebrand-syndrome-occurren 2026-08-17 monthly 0.7 https://rjrindex.com/articles/light-chain-mgus-defined-as-per-the-revised-definition-of-the-istopmm-study-experience-from-the-uni 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dermatologic-adverse-effects-with-elranatamab-mimicking-talquetamab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-plasma-based-test-for-the-measurable-residual-disease-informs-the-response-to-treatment-in-aml-pat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thalidomide-and-hydroxyurea-combination-therapy-in-transfusion-dependent-beta-thalassemia-major-a-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparison-of-80-mgkg-vs-100-mgkg-post-transplant-cyclophosphamide-dose-with-flumel-and-allogene 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dynamic-monitoring-of-circulating-tumor-dna-for-real-time-risk-assessment-in-early-stage-natural-kil 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-novel-genetic-variants-in-hyou1-on-neutrophil-phenotype 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immunophenotypic-and-cytokine-profiling-reveal-robust-immunomodulation-after-dasatinib-treatment-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/peripheral-cytopenias-and-bone-marrow-findings-in-patients-with-liver-failure-a-ten-year-retrospect 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genetic-landscape-of-pediatric-myelodysplastic-syndrome-in-japan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dxo-1801-a-liver-targeted-sirna-attenuates-inflammation-driven-iron-restriction-and-enhances-eryth 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nlrp3-inflammasome-inhibition-fails-to-prevent-red-blood-cell-lysis-in-pnh 2026-08-17 monthly 0.7 https://rjrindex.com/articles/raising-the-bar-in-maternofetal-hematology-cost-effectiveness-of-iron-deficiency-screening-in-pregn 2026-08-17 monthly 0.7 https://rjrindex.com/articles/accurate-and-automated-multi-center-tcd-velocity-analysis-using-natural-language-processing 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-protocol-of-dual-passing-cord-blood-pre-post-transplant-reduced-relapse-in-tcrav-cell-deple 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-features-and-prognostic-model-for-adenovirus-infection-following-allogeneic-hematopoietic-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/negative-regulators-of-survival-and-proliferation-nrsps-identified-by-crispr-activation-studies-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survival-trends-in-chronic-lymphocytic-leukemia-before-and-after-btk-inhibitors-era-a-seer-database 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-nutritional-anemia-related-mortality-in-the-elderly-in-theunited-states-fr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/favorable-survival-and-tolerability-of-the-gmall-protocol-in-adolescents-and-young-adults-with-all 2026-08-17 monthly 0.7 https://rjrindex.com/articles/belantamab-mafodotin-nirogacestat-and-pomalidomide-in-patients-with-relapsedrefractory-multiple-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-glofitamab-glofit-plus-gemcitabine-and-oxaliplatin-gemox-in-relapsedrefr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/global-immunopeptidome-remodeling-favors-piga-mutant-clones-in-bone-marrow-failure 2026-08-17 monthly 0.7 https://rjrindex.com/articles/talquetamab-induces-deep-responses-in-heavily-pre-treated-patients-with-systemic-light-chain-amyloid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/this-is-a-title-in-sentence-caseearly-intrathecal-dexamethasone-and-methotrexate-as-an-effective-ap 2026-08-17 monthly 0.7 https://rjrindex.com/articles/harnessing-repressive-lef1v-catenin-complexes-to-overcome-drug-resistance-in-chronic-lymphocytic-le 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improved-outcomes-following-allogeneic-hematopoietic-stem-cell-transplantation-in-patients-with-ddx4 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-of-mycosis-fungoides 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparison-of-infections-in-patients-with-chronic-lymphocytic-leukemia-cll-treated-with-btki-versu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tocilizumab-for-cytokine-release-syndrome-after-allogeneic-hematopoietic-stem-cell-transplantation-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/young-35-years-matched-sibling-donors-for-allogeneic-transplantation-with-post-transplantation-cyc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-national-lens-on-follicular-lymphoma-academic-care-linked-to-improved-survival-in-158000-patient 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-patient-characteristics-treatment-patterns-and-outcomes-among-relapsedrefractory-multi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/no-cars-for-miles-geographic-disparities-in-access-to-multiple-myeloma-car-t-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-evaluation-of-ipss-m-and-cpss-mol-in-cmml-impact-of-molecular-markers-on-prognosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-low-disease-burden-on-the-safety-and-efficacy-of-bcma-car-t-in-patients-with-relapsedrefr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/changing-dogma-regarding-mutation-primacy-in-acute-myelogenous-leukemia-protein-expression-superse 2026-08-17 monthly 0.7 https://rjrindex.com/articles/which-molecular-patterns-of-high-risk-myeloid-malignancies-are-concordantly-identified-using-two-mac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/nlrp6-regulates-zap-70-erk-signaling-in-both-murine-and-human-t-cells-and-influences-acute-graft-ver 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-a-machine-learning-model-to-predict-overall-survival-in-patients-with-peripheral-t-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/burden-of-hodgkin-lymphoma-from-1990-to-2021-and-modelled-projection-to-2050 2026-08-17 monthly 0.7 https://rjrindex.com/articles/detection-of-minute-flt3-itd-clones-at-day-30-post-allo-hsct-predicts-high-relapse-risk-and-informs 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hematopoietic-stem-cell-transplantation-for-relapsed-classical-hodgkin-lymphoma-a-benchmark-study-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/kpna2-enhances-autophagy-through-activation-of-the-non-canonical-nf-kb-signaling-pathway-thereby-pr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disparities-and-trends-in-hospice-facility-deaths-among-leukemia-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-rare-case-of-kit-negative-indolent-systemic-mastocytosis-without-anaphylaxis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/burden-of-illness-and-hematocrit-control-among-patients-with-high-and-low-risk-polycythemia-vera-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epigenetic-basis-of-mdsmpn-overlap-syndrome-with-compound-loss-of-kmt2c-and-dnmt3a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/salvage-whole-brain-radiotherapy-after-methotrexate-failure-in-primary-cns-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-orelabrutinib-based-regimens-in-the-treatment-of-marginal-zone-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/funcional-cure-in-advanced-follicular-lymphoma-real-word-experience-from-two-academic-centers-from 2026-08-17 monthly 0.7 https://rjrindex.com/articles/national-trends-in-sepsis-specific-mortality-among-adults-in-the-united-states-with-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/increased-risk-of-vaso-occlusive-crisis-in-patients-with-sickle-cell-disease-treated-with-crizanlizu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-experience-in-the-first-line-treatment-of-acute-myeloid-leukemia-with-ven-aza-optimizing 2026-08-17 monthly 0.7 https://rjrindex.com/articles/monoclonal-antibodies-against-pathogenic-s100a89-alarmins-can-restore-hematopoiesis-and-result-in-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/omic-evaluation-of-g-csf-induced-changes-in-bone-marrow-a-focus-on-lipid-metabolism 2026-08-17 monthly 0.7 https://rjrindex.com/articles/divergent-trends-in-high-bmi-associated-nhl-mortality-an-analysis-of-the-globalburden-of-disease-da 2026-08-17 monthly 0.7 https://rjrindex.com/articles/computational-immunophenotypic-profiling-of-multiple-myeloma-by-flow-cytometry-and-bioinformatics-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aplastic-anemia-treatment-in-older-adults-in-resource-limited-settings-can-rabbit-atg-bridge-the-ga 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bone-marrow-biopsy-characteristics-at-nadir-after-intensive-induction-therapy-do-not-predict-outcome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/racial-and-socioeconomic-disparities-in-smoldering-multiple-myeloma-insights-from-the-surveillance 2026-08-17 monthly 0.7 https://rjrindex.com/articles/measuring-patient-preference-information-for-blood-cancer-treatments-and-outcomes-a-systematic-revi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/willingness-to-pay-for-dlbcl-treatment-characteristics-in-japan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gwas-guided-pharmacogenomic-risk-scores-predict-premedication-related-pegaspargase-hypersensitivity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/analysis-of-factors-associated-with-clinical-response-in-glofitamabs-treatment-of-relapsed-or-refra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-assessment-of-myocarditis-in-patients-undergoing-chimeric-antigen-receptor-t-cell-therapy-a-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/autoimmune-hemolytic-anemia-aiha-associated-with-human-immunodeficiency-virus-hiv-infection-two 2026-08-17 monthly 0.7 https://rjrindex.com/articles/klippel-trenaunay-syndrome-with-multifactorial-anemiasuccessful-management-with-sirolimus 2026-08-17 monthly 0.7 https://rjrindex.com/articles/artificial-intelligencedriven-virtual-tumor-board-enhances-precision-care-in-myelodysplastic-syndro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-use-of-danicopan-as-an-add-on-therapy-in-a-ravulizumab-treated-adult-patient-with-paroxysmal-noc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/singlecell-analysis-of-bax-responses-reveals-venetoclax-sensitivity-and-enables-development-of-bax 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rpt1g-a-novel-hyperbolic-nampt-inhibitor-is-highly-effective-against-b-cell-non-hodgkins-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identification-and-characterization-of-human-erythroblastic-islands-ebis-at-single-cell-resolution 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcome-subgroups-and-associated-determinants-in-hematologic-malignancies-a-latent 2026-08-17 monthly 0.7 https://rjrindex.com/articles/docirbrutinib-as-1763-a-novel-non-covalent-btk-inhibitor-demonstrates-efficacy-in-btk-inhibitor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/flt3-f691l-confers-kinase-independent-resistance-via-grb2-dependent-mapk-signaling-in-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-inpatient-outcomes-and-resource-utilization-in-multiple-myeloma-an-nis-based 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evolutionarily-divergent-notch-regulation-underpins-the-initiation-of-human-t-cell-development 2026-08-17 monthly 0.7 https://rjrindex.com/articles/t-cell-fitness-and-tumor-specificity-predict-immunotherapy-response-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-of-returning-to-work-and-disability-pension-in-multiple-myeloma-patients-in-central-norway 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-update-on-safety-and-efficacy-of-low-dose-post-transplant-cyclophosphamide-in-the-hla-mism 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-cohesin-complex-gene-mutations-on-clinical-outcomes-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/can-we-perform-allogeneic-hematopoietic-cell-transplantation-hct-safely-in-patients-with-limited-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-supported-insight-generation-to-inform-medical-education-priorities-in-multi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mitoxantrone-liposome-subcutaneous-cytarabine-and-g-csf-cmg-combined-with-venetoclax-as-first-lin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-and-characteristics-of-patients-treated-with-frontline-intensive-chemotherapy-versus-hypome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/guaranteed-care-uncertain-meals-when-universal-coverage-fails-to-feed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/advanced-practice-provider-led-programs-improve-patient-access-the-app-lymphoma-diagnostic-program 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-prolong-trial-a-two-phase-randomized-placebo-controlled-trial-to-optimize-rituximab-response-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-of-platelet-transfusion-and-clinical-outcomes-in-chimeric-antigen-receptor-t-cell-therap 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-combinatorial-caar-t-cell-strategy-to-eliminate-factor-viii-inhibitors-in-preclinical-models-of-he 2026-08-17 monthly 0.7 https://rjrindex.com/articles/oral-azacitidine-maintenance-improved-survival-for-t-aml-or-aml-mr-patients-in-first-remission-after 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-initiation-pattern-ramp-up-measures-and-management-of-aml-patients-treated-in-real-life-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/azacitidine-panobinostat-activates-nf-kb-signaling-in-the-bone-marrow-microenvironment-to-chemosensi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-nucleotide-metabolism-to-enhance-ara-c-sensitivity-in-myeloid-leukemia-associated-with-dow 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimizing-establishment-of-high-need-pediatric-acute-myeloid-leukemia-aml-patient-derived-xenogra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/underexplored-mutations-in-plasma-cell-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-orelabrutinib-monotherapy-in-patients-with-chronic-lymphocytic-leukemia-a-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/malnutrition-an-underrecognized-comorbidity-in-hematologic-malignancies-in-a-single-institution-rev 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-risk-stratification-of-myelodysplastic-syndromes-in-brazil-a-cohort-applying-ipss-m-and-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genetic-risk-stratification-in-adults-with-aml-receiving-venetoclax-based-intensive-therapy-a-real 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparable-remission-rates-in-therapy-related-and-myelodysplasia-related-acute-myeloid-leukemia-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-and-clinical-evaluation-of-a-cost-effective-method-with-capillary-electrophoresis-sequen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/zanubrutinib-plus-r-chop-versus-r-chop-as-first-line-therapy-in-double-expressor-dlbcl-a-multicente 2026-08-17 monthly 0.7 https://rjrindex.com/articles/defining-clinical-risks-of-venous-thromboembolism-in-children-with-intestinal-failure 2026-08-17 monthly 0.7 https://rjrindex.com/articles/synergistic-efficacy-and-preliminary-molecular-mechanisms-of-venetoclax-combined-with-microtransplan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dysregulation-of-fibrinolysis-and-its-relationship-with-blood-cellular-indices-in-acute-pulmonary-em 2026-08-17 monthly 0.7 https://rjrindex.com/articles/locally-deployed-large-language-models-for-automated-data-curation-in-allogeneic-hematopoietic-stem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/frontline-tyrosine-kinase-inhibitor-selection-influences-eventual-treatment-free-remission-eligibili 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-and-genomic-landscape-of-stat5b-mutations-in-lymphoid-and-myeloid-malignancies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dnmt1-mediated-epigenetic-regulation-of-heterochromatin-in-cellular-aging 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-of-venous-thromboembolism-associated-with-cdk-46-inhibitors-and-adjuvant-hormonal-therapy-in-n 2026-08-17 monthly 0.7 https://rjrindex.com/articles/standard-transcranial-doppler-as-a-resource-efficient-first-step-to-screen-for-mra-defined-cerebral 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genomic-and-transcriptomic-characterization-of-acute-myeloid-leukemia-with-cd123-overexpression 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-car-t-cell-therapies-after-prior-treatment-with-fixed-duration-mosunetuzumab-in-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-mechanisms-of-cell-based-blood-coagulation-roles-of-integrin-v3-psi-domain-and-its-l33p-polym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cytomegalovirus-cmv-reactivation-negatively-impacts-survival-after-car-t-cell-therapy-in-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-safety-of-tislelizumab-maintenance-therapy-following-autologous-stem-cell-tran 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-obinutuzumab-in-frontline-and-rr-cll-outcomes-compared-to-age-and-sex-matched-general 2026-08-17 monthly 0.7 https://rjrindex.com/articles/slf2-and-smc5-are-novel-causative-genes-for-inherited-bone-marrow-failure-syndromes-driving-hsc-agi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/social-vulnerability-predicts-higher-county-level-pulmonary-embolism-mortality-in-the-united-states 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dara-rvd-in-newly-diagnosed-multiple-myeloma-real-world-clinical-practice 2026-08-17 monthly 0.7 https://rjrindex.com/articles/socioeconomic-inequality-in-acute-myeloid-leukaemia-treatment-in-england-what-drives-this-inequalit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/validation-of-the-flil6-score-a-new-dynamic-cytokine-based-risk-model-in-adults-with-acute-myeloid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/silibinin-enhances-daunorubicin-chemosensitivity-in-acute-myeloid-leukemia-by-suppressing-pdia3-medi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/low-levels-of-enhancer-of-zeste-homolog-2-ezh2-protein-are-prognostically-adverse-and-independent 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-protein-expression-of-mds1-and-evi1-complex-locus-mecom-is-prognostically-adverse-and-indepen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/splenic-dysfunction-in-young-children-with-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/measles-vaccine-induced-sero-protection-among-children-with-sickle-cell-anemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-reproductive-health-service-delivery-at-nascc-recognized-comprehensive-sickle-cell-center 2026-08-17 monthly 0.7 https://rjrindex.com/articles/complement-dysregulation-during-vaso-occlusive-episodes-can-predict-development-of-acute-chest-syndr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-dll4-enhancer-regulates-sinusoidal-niche-mediated-hsc-proliferation-and-maintenance 2026-08-17 monthly 0.7 https://rjrindex.com/articles/subclonal-genomic-heterogeneity-shapes-immune-crosstalk-and-clinical-outcomes-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/all-19-subjects-with-transfusion-dependent-v-thalassemia-achieved-transfusion-independence-after-tre 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evolving-catastrophic-antiphospholipid-syndrome-with-intracerebral-hemorrhage-treatment-with-plasma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/uncovering-bispecific-antibody-mechanisms-via-3d-superresolution-imaging-of-t-cell-tumor-cell-membra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hypermethylation-of-the-ribosomal-dna-coding-sequence-and-disordered-transcription-factor-binding-as 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disparities-related-to-myelofibrosis-a-retrospective-analysis-of-us-mortality-data 2026-08-17 monthly 0.7 https://rjrindex.com/articles/continued-risk-of-relapse-in-peripheral-t-cell-lymphoma-even-in-patients-who-achieved-complete-respo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/experience-with-prolgolimab-in-the-treatment-of-patients-with-relapsed-and-refractory-classical-hodg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-effectiveness-of-brentuximab-vedotin-in-chinese-adult-patients-with-classical-hodgkins-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/glp-1-receptor-agonist-use-is-associated-with-lower-risk-of-progression-from-mgus-to-smm-or-mm-in-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-inflammation-in-sickle-cell-disease-association-of-glp-1-agonist-use-with-improved-surviv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/shear-wave-elastography-as-a-screening-modality-for-hepatic-fibrosis-in-a-comprehensive-sickle-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-concentrations-of-17v-estradiol-suppress-coro7-and-impair-megakaryocyte-proplatelet-formation-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/causal-role-of-gut-microbiota-in-immune-thrombocytopenia-a-systematic-review-of-mendelian-randomiza 2026-08-17 monthly 0.7 https://rjrindex.com/articles/increased-alemtuzumab-exposure-correlates-with-improved-responses-in-heavily-pretreated-rr-all-pati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/spanish-real-life-practice-confirms-zanubrutinib-as-a-safe-and-effective-option-in-relapsed-or-refra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/adenosine-pathway-as-a-therapeutic-target-in-diffuse-large-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/morphology-guided-spatial-transcriptomics-to-study-topography-of-hodgkin-reed-sternberg-cells-intera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-luspatercept-in-adults-and-adolescents-with-a-thalassemia-findings-from-the-dose 2026-08-17 monthly 0.7 https://rjrindex.com/articles/total-effect-of-gestational-hypertension-on-neonatal-iron-deficiency-in-very-preterm-infants 2026-08-17 monthly 0.7 https://rjrindex.com/articles/registration-and-characterization-of-patients-with-glucose-6-phosphate-dehydrogenase-deficiency-in-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/describing-the-feasibility-and-acceptability-of-an-electronic-adherence-monitor-to-measure-hydroxyur 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-dose-iv-ferric-derisomaltose-improves-hematologic-and-patient-reported-outcomes-in-pregnant-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/biomarkers-of-ineffective-erythropoiesis-in-patients-with-transfusion-dependent-thalassemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-romiplostim-n01-combined-with-cyclosporine-in-refractory-aplastic-anemia-pati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/overlap-of-post-car-t-hlh-toxicity-definitions-and-their-prognostic-significance-in-children-and-you 2026-08-17 monthly 0.7 https://rjrindex.com/articles/superior-real-world-outcomes-of-lisocabtagene-maraleucel-in-chronic-lymphocytic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-clinical-overview-of-infection-in-patients-receiving-elranatamab-elra-in-combination-with-daratu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mbs314-a-gprc5dxbcmaxcd3-trispecific-antibody-in-relapsedrefractory-multiple-myeloma-rrmm-upda 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-in-combination-with-hypomethylating-agents-shows-promising-activity-in-acute-myeloid-leuk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-anti-leukemia-activity-from-a-phase-1-study-of-cln-049-a-novel-anti-flt3-x-anti-cd3-bis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sustained-remission-following-limited-duration-of-bispecific-antibody-therapy-in-patients-with-relap 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-2-trial-of-zilovertamab-vedotin-in-combination-with-cyclophosphamide-doxorubicin-and-prednis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-safety-and-efficacy-of-myeloablative-orca-q-with-tacrolimus-or-without-graft-versus-host 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-bleeding-outcomes-of-direct-oral-anticoagulants-versus-warfarin-in-adults-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fertility-preservation-in-aya-oncology-provider-knowledge-gaps-counseling-practices-and-barriers 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bridging-therapy-response-and-low-pre-lymphodepletion-plasma-cell-burden-are-associated-with-improve 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-vivo-car-t-generation-using-an-engineered-lentiviral-vector-platform-targeting-bcma-cd19-and-cd2 2026-08-17 monthly 0.7 https://rjrindex.com/articles/camelot-2-a-phase-3-randomized-double-blind-placebo-controlled-study-of-bleximenib-venetoclax-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ziftomenib-in-combination-with-venetoclax-and-azacitidine-in-relapsedrefractory-npm1-m-or-kmt2a-r-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficient-prime-editing-of-human-hematopoietic-stem-cells-corrects-the-recurrent-sbds-c2582tampg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/3-year-follow-up-of-the-s1826-study-confirms-improved-progression-free-survival-with-nivolumab-avd-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/results-from-paradigm-a-phase-2-randomized-multi-center-study-comparing-azacitidine-and-venetoclax 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-free-remission-after-asciminib-abl001-based-therapy-in-chronic-phase-chronic-myeloid-leu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-idh1-inhibition-with-ivosidenib-as-maintenance-therapy-after-ivosidenib-azaciti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fixed-duration-preemptive-rituximab-maintenance-over-two-years-in-recurrent-thrombotic-thrombocytope 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-venetoclax-plus-cag-cytarabine-aclarubicin-g-csf-regimen-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-ghd-t-cell-engager-platform-for-cancer-immunotherapy-promoted-t-cell-expansion-with-a-persisten 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-combined-with-five-days-of-azacitidine-for-the-treatment-of-previously-untreated-acute-my 2026-08-17 monthly 0.7 https://rjrindex.com/articles/post-allogeneic-hematopoietic-cell-transplantation-outcomes-are-similar-after-hypomethylating-agent 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chemotherapy-selects-for-myeloid-subclones-in-multiple-subtypes-of-b-cell-acute-lymphoblastic-leukem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-chimeric-antigen-receptor-car-product-cell-phenotypes-on-clinical-outcomes-following-tre 2026-08-17 monthly 0.7 https://rjrindex.com/articles/differentiation-of-human-induced-pluripotent-stem-cells-expressing-chimeric-antigen-receptors-into-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-low-intensity-treatment-strategies-and-outcomes-in-patients-with-accelerated-phase-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-of-thrombosis-in-multiple-myeloma-patients-treated-with-carfilzomib-based-regimens-a-systemati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-a-phase-2a-study-of-gi-102-cd80il2v3-as-a-consolidation-therapy-in-patients-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-flag-ida-salvage-therapy-in-relapsedrefractory-aml-and-validation-of-the-sal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characteristics-and-outcomes-in-acute-myeloid-leukemia-with-mecom-rearrangement-treated-with-hypomet 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-toxicities-of-elranatamab-elra-in-relapsedrefractory-multiple-myeloma-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-the-development-of-second-primary-malignancies-after-allogeneic-stem-cell-he 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-outcome-and-risk-factors-for-relapse-in-pediatric-warm-autoimmune-hemolytic-anemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-antibiotic-timing-on-survival-outcomes-in-cd19-and-bcma-car-t-cell-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trials-in-progress-a-phase-ii-study-of-pirtobrutinib-in-combination-with-rituximab-in-untreated-ma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sphingosine-1-phosphate-receptor-modulators-overcome-flt3-inhibitor-resistance-in-acute-myeloid-leuk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-i-trial-of-ruxolitinib-plus-fostamatinib-for-the-treatment-of-steroid-refractory-chronic-graft 2026-08-17 monthly 0.7 https://rjrindex.com/articles/talquetamab-in-relapsedrefractory-multiple-myeloma-with-renal-impairment-a-quaternary-cancer-cente 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-characteristics-and-outcomes-of-newly-diagnosed-multiple-myeloma-patients-receiving-autol 2026-08-17 monthly 0.7 https://rjrindex.com/articles/healthcare-providers-knowledge-and-attitudes-toward-venous-thromboembolism-prophylaxis-in-multiple 2026-08-17 monthly 0.7 https://rjrindex.com/articles/low-skeletal-muscle-mass-and-cancer-cachexia-among-patients-with-multiple-myeloma-undergoing-car-t-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pregnancy-associated-atypical-hemolytic-uremic-syndrome-a-systematic-review-and-meta-analysis-of-cl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/proteomic-study-of-extracellular-vesicles-reveals-novel-biomarkers-for-pathogenesis-of-immune-thromb 2026-08-17 monthly 0.7 https://rjrindex.com/articles/shifting-treatment-paradigms-lead-to-improved-overall-survival-in-acute-myeloid-leukemia-real-world 2026-08-17 monthly 0.7 https://rjrindex.com/articles/asciminib-asc-in-chronic-myeloid-leukemia-in-chronic-phase-cml-cp-efficacy-and-safety-results-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparing-the-diagnosis-disease-and-treatment-experience-of-essential-thrombocythemia-from-clinici 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tri-partied-analyses-define-clinical-outcomes-and-molecular-features-of-patients-pts-with-acute-pr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tet2-associated-inflammatory-signaling-alters-healthy-hematopoiesis-with-clonal-expansion 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pitpv-loss-disrupts-malignant-pakt-activation-to-ameliorate-jak2-v617f-induced-myeloproliferative-ne 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-transcriptomic-analysis-reveals-ifngil-6-mediated-inflammatory-networks-in-der17q10 2026-08-17 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-driven-gvhd-scoring-and-response-tracking-advancing-fact-compliance-clini 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-zanubrutinib-in-waldenstrom-macroglobulinemia-patients-treated-in-common-clin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epidemiological-and-molecular-analysis-of-thalassemia-beta-globin-gene-in-the-heterogeneous-popula 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterization-and-risk-factors-of-transplantation-associated-thrombotic-microangiopathy-ta-tma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-unseen-crisis-the-gap-between-recommendations-and-reality 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-von-willebrand-factor-targeting-thrombolytic-tgd001-is-effective-in-diverse-thrombotic-models 2026-08-17 monthly 0.7 https://rjrindex.com/articles/modifiable-lifestyle-factors-in-patients-with-myeloproliferative-neoplasms-in-the-california-teacher 2026-08-17 monthly 0.7 https://rjrindex.com/articles/application-of-polycythemia-vera-guidelines-in-pediatric-patient-with-erythrocytosis-a-case-series 2026-08-17 monthly 0.7 https://rjrindex.com/articles/biomarker-analysis-to-unravel-mechanisms-of-resistance-to-glofitamab-monotherapy-in-large-b-cell-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/distinct-patterns-of-bone-marrow-complement-and-immunoglobulin-deposition-define-unique-clinicopatho 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-donor-kir-genotypes-on-clinical-outcomes-in-pediatric-allogeneic-hematopoietic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evolving-prognostic-impact-of-b-symptoms-in-non-hodgkin-lymphoma-a-competing-risks-analysis-of-seer 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-infection-related-mortality-among-non-hodgkin-lymphoma-patients-in-the-uni 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evolving-burden-of-acute-kidney-injury-in-non-hodgkins-lymphoma-hospitalizations-a-seven-year-nati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multi-hit-tp53-mutation-is-an-independent-adverse-prognostic-factor-in-allogeneic-hematopoietic-stem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-class-transition-from-bortezomib-to-ixazomib-based-regimens-in-transplant-ineligible-patients-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/predictors-of-early-mortality-in-acute-myeloid-leukemia-a-population-based-analysis-using-seer-data 2026-08-17 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-cancer-associated-venous-thromboembolism-mortality-a-nationwide-analysis-1999-2 2026-08-17 monthly 0.7 https://rjrindex.com/articles/replicative-stress-induced-aging-of-hematopoietic-stem-progenitor-cells-increases-oncogenic-mutation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cardioembolic-stroke-in-children-and-young-adults-comprehensive-management-and-risk-of-hemorrhagic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrated-single-cell-and-spatial-analysis-identifies-t-cell-exhaustion-and-adhesion-signatures-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ankrd26-related-thrombocytopenia-hematologic-malignancy-characteristics-clinical-outcomes-and-pre 2026-08-17 monthly 0.7